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GLYCOPROTEIN BIOSYNTHESIS; SOME ASPECTS OF REGULATION
CHAPTER I 
INTRODUCTION
Plasma Glycoproteins in Health and Disease 
With the exception of albumin, almost all plasma proteins are 
glycoproteins and their concentrations, within limits, are fairly constant 
in healthy adult individuals. Seasonal and diurnal variations do occur, 
however (1). Glycoprotein levels are slightly higher in males as com­
pared to females and there is a gradual increase in their concentrations 
in both sexes with advancing age (2). The protein-bound carbohydrates of 
fetal blood differ qualitatively and quantitatively from those of normal 
adults (3) and there is a marked increase in serum protein-bound hexose 
and hexosamine during pregnancy (4). These normal, physiological varia­
tions are of interest but most attention has been focused on the striking 
changes produced in the levels of a number of plasma glycoproteins by 
various pathological processes. Some of these are briefly discussed 
below.
Rheumatic Disorders 
Increases in serum glycoproteins are associated with a number 
of inflammatory diseases, notably rheumatic fever and rheumatoid arthritis
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(5). A positive correlation between the changes in serum levels of 
glycoproteins and the exacerbation of rheumatic diseases has been found 
in a number of cases (6), and Robinson and Roseman (7) have stated that 
all rheumatic diseases exhibit such changes in the acute stage. Corti­
sone therapy has been found to be effective in normalizing the elevated 
levels of protein-bound hexose in such cases (8). The increase in serum 
glycoprotein concentration is reflected mainly in the a2“êlobulin and 
seromucoid fractions (9). Yachi et al. (10) identified some specific 
components of these fractions as orosomucoid, a^-antitrypsin, and hapto­
globin. The increased concentrations of these proteins were considerably 
reduced by treatment with anti-inflammatory agents like oxyphenbutazone 
and betamethasone.
Diabetes
In spite of a few contradicting reports (11, 12), it appears 
that uncomplicated diabetes mellitus is not associated with significant 
changes in serum levels of glycoproteins (13, 14). Protein-bound hexose 
and hexosamine, however, are increased significantly in diabetes mellitus 
complicated with degenerative vascular diseases (15). Serum glyco­
proteins have been found to increase by 60% in diabetic angiopathy (16).
Myocardial Infarction 
Myocardial infarction leads to an increase in serum levels of 
a^- and o^-globulins including seromucoid and 0 2 -glycoprotein, with a 
maximum being reached on the sixth and seventh days (17, 18). The 
globulin level is more closely related to clinical severity than the 
a2 ~globulin level. The serum level of albumin is simultaneously decreased.
Cancer
Plasma levels of some glycoproteins are significantly elevated 
in a number of neoplastic diseases (19-21). The C-reactive protein, 
which is usually not detectable in human plasma, is present in 60% of the 
patients with clinical cancer (22, 23). Lung cancer has been shown to be 
associated with hypoalbuminemia, an increase in a^- and a2“globulins and 
a lesser increase in 3-globulins (24). The concentrations of hexose, 
hexosamine and sialic acid are considerably elevated in the plasma of 
children suffering from acute leukemia and their levels tend to decrease 
during clinical remissions of the disease (25). Perchlorate-soluble 
serum proteins (seromucoid) show a marked increase in the blood of people 
afflicted with sarcomas and carcinomas (26, 27) .
A fetal glycoprotein closely related to fetuin has been reported 
to appear in the plasma of patients afflicted with primary liver hepatoma 
(28). It has been hypothesized that the synthesis of this protein, which 
is normally terminated at the time of birth, is resumed during oncogenesis 
by cells which have returned to a more primitive state.
Marked increases in the levels of serum protein-bound hexose, 
hexosamine, fucose, and sialic acid have also been found in Hodgkin's 
disease (29, 30), but attempts to correlate their indices with the 
clinical state have not been fruitful. The appearance of C-reactive 
protein in significant amounts in the sera of patients with Hodgkin's 
disease is a typical observation (31).
Infections
Increases in plasma glycoproteins have been found in clinical 
and experimental tuberculosis (32), pneumonia (32, 33), and a number of
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other Infectious diseases (34) and may indicate a general response to 
tissue damage and stress.
Trauma
Alterations in the level of plasma glycoproteins are not unique 
to the diseased state. Similar effects can be produced by tissue injury 
and experimental inflammation (stress) in a wide variety of forms.
Weimer et al. (35) have detected pronounced elevations in fibrinogen, 
seromucoid, and in “i-, and o^-globulins after adjuvant-induced arthritis. 
Accidental and surgical trauma, bone fractures, hemorrhage, burns, freez­
ing, Y-irradiation, intense physical exercise and a number of environmen­
tal factors cause marked increases in a-globulins, reaching a maximum 
between 24 to 48 hours after the stimulus (36-38). Injections of sterile 
Celite, talcum, turpentine, croton oil, and subcutaneous sponge implanta­
tion have been widely used to produce the response. The stress-responsive 
glycoproteins, referred to by many authors as "acute phase reactants," 
primarily include haptoglobin, orosomucoid, the ^1-acid glycoprotein of 
Darcy and that of Shultze, ceruloplasmin, ai-antitrypsin, C-reactive 
protein, fibrinogen, and a2“^cute phase («2-4?) globulin (39-48).
The increases in serum proteins seen after stress do not result 
from a decrease in their catabolic rates; in fact, their catabolism, if 
affected at all, is slightly increased (36, 38, 49). Furthermore, the 
stress-induced increases can be abolished by injections of actinomycin D, 
ethionine, or puromycin, indicating that the elevated levels of these 
glycoproteins result from an increased rate of biosynthesis (50, 51).
Partial Hepatectomy
Since the liver has been established as the major site of
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plasma protein synthesis (52), partial hepatectomy, in addition to injury, 
can also be used as a model for studying the regulation of glycoprotein 
metabolism. Although the circulating levels of most plasma proteins do 
not increase, but actually decrease after partial hepatectomy (52) , the 
synthetic rates of most, if not all of them, are markedly increased. 
Chandler and Snider (53) and Majumdar et al. (54) have reported signifi­
cant increases in the relative synthetic rates of albumin, fibrinogen, 
and the seromucoid fraction after partial hepatectomy. Mutschler and 
Gordon (55), and Infante et al. (56) have found similar increases in 
plasma protein synthesis in the isolated, perfused, regenerating rat 
liver. Thus, the decrease in the level of many plasma proteins observed 
after partial hepatectomy does not result from a diminution in their 
rates of synthesis but from an increase in their rates of degradation 
and from a reduced organ mass (57).
Significance of Plasma Glycoprotein Changes 
In the light of rather scanty information available as to their 
true biological role, explanations regarding the physiological signifi­
cance of an increase in the levels of certain plasma glycoproteins in 
response to stress can only be based on liberal conjecture. An increase 
in the level of a^-antitrypsin may represent a need to inhibit proteolytic 
enzymes released after injury (58). Increases in haptoglobin may reflect 
a greater need for binding hemoglobin liberated as a result of hemolysis 
(36). Similarly, greater amounts of ceruloplasmin, transferrin and 
G2-glycoprotein may be required to entrap copper, iron, and zinc, 
respectively, which are needed as cofactors in many enzymatic reactions 
and may also be toxic in high concentrations in the free form. Increased
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quantities of a2 -macroglobulin may serve to bind various toxic substances 
set free during Injury (59). Increased amounts of fibrinogen, of course, 
would accelerate blood clotting (36). Some glycoproteins are required 
for binding and carrying hormones. Reappearance of specific fetal and 
neonatal plasma proteins might play a part In the regeneration and repair 
of damaged tissue (60, 61). Some unusual proteins like C-reactlve protein 
which appear in Hodgkin's disease and In some cancer subjects might have 
a role to play in the regulation of cell division (61).
Endocrine Regulation of Plasma Protein Metabolism
Hormonal regulation of plasma glycoprotein synthesis Is one of 
the most extensively studied, yet most poorly understood, areas of 
glycoprotein metabolism. Most hormones appear to have a non-specific 
effect on glycoprotein synthesis and none of them seem to be absolutely 
necessary for Inducing the stress-specific response. Some examples of 
endocrine involvement in plasma protein metabolism are discussed below.
Growth Hormone
Hypophysectoray in rats causes a reduction in the albumin and 
a^-globulin fractions of serum proteins which Is overcompensated by 
growth hormone (GH) administration (62, 63). Bovine GH can cause a 
significant Increase In fibrinogen synthesis in rats within a few hours 
after administration (64).
The stimulatory effect of GH on plasma protein synthesis has 
also been demonstrated in a number of In vitro studies. Jefferson and 
Komer (65) were able to show that GH stimulates amino acid incorporation 
Into proteins in the isolated, perfused rat liver. This stimulation
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occurred, however, only when the concentration of the amino acids in the 
perfusate was raised several-fold over the normal. Similar results were 
obtained from experiments with liver slices (66).
Liver slices from hypophysectomized rats show a marked reduction 
in their ability to incorporate radioactive precursors into ribonucleic 
acid (RNA) and protein (67). The amount of polysomes is drastically 
reduced and their amino acid incorporating ability is badly impaired 
following hypophysectomy (68, 69). The degree of stimulation of 
phenylalanine incorporation by polyuridylic acid into disaggregated 
polysomes obtained from hypophysectomized animals is less than that into 
comparable preparations from the intact animals (70, 71). All of these 
parameters return to normal when hypophysectomized animals are treated 
with GH.
Barden and Komer (72) reconstituted rat liver ribosomes by 
hybridizing 40 and 60 S subunits isolated from normal and hypophysecto­
mized animals and discovered that hypophysectomy specifically affected 
the 40 S subunit, since ribosomes containing this subunit from hypophy­
sectomized rats showed a lower activity in amino acid incorporating 
systems. This work was contradicted, however, by Foster and Sells (73) 
who found that 80 S ribosomes prepared by reassociation, in all possible 
combinations, of 40 and 60 S subunits from normal and hypophysectomized 
animals were equally active in vitro.
The experimental evidence accumulated so far, indicates that 
GH stimulates protein synthesis in general. Even though plasma GH levels 
are elevated after surgery (74), GH probably does not exert a specific 
effect on the synthesis of individual serum proteins since the normal
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response to stress Is seen after hypophysectomy (75) and GH has little 
or no effect on plasma protein synthesis by the perfused liver (76).
Tata (77) has, however, presented an idea that could explain selective 
increases in the synthesis of certain plasma proteins by GH. He has 
suggested that regulation of protein synthesis by growth and develop­
mental hormones may be largely mediated through newly formed ribosomes.
A topographical segregation and redistribution of polyribosomes by 
attachment to cytoplasmic membranes, which are generated in parallel 
with the additional ribosomes, could in this way facilitate the synthesis 
of specific proteins. The idea of differential synthesis of each plasma 
protein by a separate population of ribosomes seems to be attractive but 
needs more experimental support.
Insulin.
Insulin seems to exert a general effect on protein synthesis 
resembling that of GH. Liver microsomes from alloxan diabetic rats 
incorporate less amino acids into proteins than do microsomes from normal 
rats and insulin replacement restores full activity (78, 79). Liver 
perfusion studies (76) support earlier in vivo findings that insulin has 
a general stimulatory action on protein synthesis and is not in itself 
responsible for producing the stress-specific response. This effect on 
general protein synthesis may be observed to influence plasma protein 
synthesis under certain conditions. For example, Balegno and Neuhaus 
(80) have recently reported that the early stimulation of serum albumin 
synthesis following injury is dependent on insulin because this response 
to stress is suppressed in alloxan-diabetic rats and is restored by 
insulin therapy.
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Adrenocorticotropic Hormone (ACTH) and Adrenocortlcosteroids
One of the most striking aspects of the endocrine response to 
stress is the increased activity of the adrenal cortex. Most types of 
injuries in man and animals are accompanied by increased plasma levels 
of corticosteroids within 5 to 6 hours after injury (38, 75). This 
increase in plasma cortisol in man has been found to parallel increases 
in plasma levels of ACTH (36, 75, 81). Corticosteroids and ACTH produce 
an increase in serum hexosamine, and in dogs, cortisone increases the 
level of Oj^-globulin (36). Injections of ACTH lead to a marked increase 
in plasma levels of fibrinogen in rats and rabbits (82).
Weimer (83) reported that adrenalectomy caused a pronounced 
reduction in the response of a2~AP globulin and of seromucoid to tissue 
injury in rats. Moderate doses (0.6mg/100g) of cortisol fully restored 
the normal response to injury, but higher doses (>0.6mg/100g) were found 
to be inhibitory. John and Miller (76) were able to produce marked in­
creases in fibrinogen, haptoglobin, aĵ -acid glycoprotein and a2~AP 
globulin synthesis in isolated, perfused rat liver by infusing cortisol, 
expecially when supplemented with insulin, GH and a complete amino acid 
mixture. These increases were critically dependent upon the presence of 
cortisol.
Leon (84) observed a 118% increase in the amino acid incorpo­
rating ability of liver microsomes isolated from rats 30 minutes after a 
single injection of corticosterone. Similarly, Angelov and Richter (85) 
showed a 200% increase in the uptake of tyrosine^^-C into liver micro­
somal proteins within 4 hours after hydrocortisone injections (Img/g).
Intraperitoneal injections of hydrocortisone-21-phosphate
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(1.4mg/100g) to rats have been claimed to increase the synthesis of 
DNA-like KNA by 32% and total nuclear KNA by 11% C86).
The work cited above supports the idea that the stress-induced 
increase in plasma glycoprotein synthesis may be mediated by adreno­
cortical hormones. This concept, though appealing, is not all that clear. 
There are many reports in the literature that support the opposite point 
of view. For example, Kataja and Staehlin (87) observed an increase in 
leucine-l^C incorporation into rat liver ribosomes following adrenalec­
tomy. Ribonucleoprotein-particles from livers of adrenalectomized rats 
were found to incorporate twice as much leucine-^into protein as did 
those from normal animals (88); treatment with corticosterone abolished 
this effect. Koike et al. (89) have observed an early stimulation 
(30-60 min.) of protein synthesis followed by a marked depression (4-5 
hours) in livers from adrenalectomized mice after cortisone administra­
tion. Hydrocortisone has been reported to depress RNA and protein 
synthesis in plasmacytoma Tu X-5563 cells (90).
Thus it is clear that the effects of corticosteroids on protein 
metabolism are exceedingly complex. The marked discrepancies in results 
obtained by various investigators after ACTH and corticoid treatment are 
probably due to differences in dosage, timing, species and other factors. 
In addition, it is also apparent that the corticosteroids exert different 
effects on different proteins; i.e., stimulate the synthesis of some and 
depress that of others.
As far as the acute-phase response to stress is concerned, it 
appears that, although the corticosteroids play an important role in 
inducing a proper response, they are not the sole factors involved. It
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has been reported, for example, that adrenalectomy does not abolish the 
increase in the seromucoid fraction or the increase in amino acid incor­
poration into microsomes normally observed following stress. It does, 
however, cause a marked shift in the pattern of response; i.e., the 
response is delayed (91). Replacement therapy with glucocorticoids 
restores a normal pattern of response, but only if initiated during the 
early phase of the response. Excessive doses (3.75 mg/lOOg) of cortisone 
suppress the seromucoid response in adrenalectomized rats and stimulate 
the synthesis of serum albumin.
Experiments like these, and others, have led various investi­
gators (36, 75, 91) to propose that corticosteroids have only a permis­
sive role to play in plasma protein synthesis--- their presence is
necessary for the metabolic response to occur but they are not directly 
involved in producing the specific changes.
Very little is known about the mechanism of action of these 
hormones. Beato et al. (92) studied the subcellular distribution of 
radioactivity in rat liver after intraperitoneal injections of tritiated 
cortisol and found that the bulk of radioactivity was in the cytoplasmic 
fraction; only 0.2-0.4% was recovered bound to protein in purified 
nuclei. About 10% of the cytoplasmic radioactivity existed as cortisol 
associated with protein. The authors suggested that cortisol exerted 
its effect on RNA synthesis by binding to a specific protein having a 
regulatory function. Louisot and coworkers (93, 94) have reported that 
injections of 3', 5'-cyclic-AMP can increase the steroid binding activity 
of transcortin at the subcellular level in rat liver cells with a 
simultaneous increase in glucosamine-^H incorporation into glycoproteins.
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A general Increase in liver tBNA synthesis following cortisone injections 
has been seen by Agarwal et al. (95, 96).
Various models for the transcriptional and translational con­
trol of protein synthesis by hormones have been presented by Tata (97), 
Kenney (98), O'Malley (99), Tomkins (100), Britten and Davidson (101), 
and Budavari (102). Although each of these has some attractive features 
for a specific system or a specific hormone, it is clear that none 
adequately accounts for all the phenomena observed.
Initiation and Relay of the Stress Response
The process by which the "stress signal" from a remote site 
reaches the liver is another equally puzzling and intriguing aspect of 
the stress-induced increase in hepatic glycoprotein synthesis. Most 
conditions, discussed in the beginning of this chapter, that cause marked 
alterations in the levels of plasma proteins do not directly affect the 
liver. Thus there must be a specific mechanism for relaying the signal 
to this organ. Cuthbertson (38) has presented evidence suggesting that 
such a response could be mediated by an indirect stimulation of the CNS 
by afferent impulses originating at the site of injury. A number of 
experiments involving transections of various nerves or the spinal cord 
seem to support this idea. Injury to an animal whose pituitary is 
isolated from hypothalamic control by dividing the stalk, however, is 
capable of causing a brisk adrenocortical response (73). Consequently, 
a number of investigators (75, 103-106) have suggested that the response 
is produced by some humoral factor(s) or local hormone such as histamine,
5-hydroxytryptamine, bradykinin, or acetylcholine released from the 
damaged tissue, which could directly stimulate the adrenal cortex.
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Structure of Glycoproteins 
A knowledge of the structure of glycoproteins is helpful for 
understanding the mechanisms of their biosynthesis and regulation. 
Glycoproteins are distinguished from other proteins by the presence of 
one .or more carbohydrate moieties covalently linked to the polypeptide 
chains. The sugars most commonly found in plasma glycoproteins are: N-
acetyl-D-glucosamine, N-acetyl-D-galactosamine, D-mannose, D-galactose, 
L-fucose, and sialic acids. L-Fucose and sialic acids have invariably 
been found to occupy a terminal position at the non-reducing end of the 
carbohydrate chains. The innermost sugar residue that links the hetero­
saccharide chain to the polypeptide backbone is either N-acetylglucos­
amine bonded to the amide nitrogen of asparagine (107), or N-acetyl- 
galactosamine linked to the hydroxyl group of serine or threonine (108). 
Both linkages are found in plasma glycoproteins, but the predominant 
linkage is that to asparagine. The core of the heterosaccharide chains 
is usually made up of mannose and N-acetylglucosamine residues.
Although the carbohydrate composition of many glycoproteins is 
known in terms of the percentage and number of each sugar residue per 
mole, the exact sequence of sugars in the heterosaccharide chains of 
each glycoprotein has been determined in only a relatively few cases. 
Sugar sequences proposed for some glycopeptides of the type found in 
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In spite of considerable variations found in the number and 
sequence of sugar residues in the carbohydrate moieties of various plasma 
glycoproteins, a general structural pattern can be formulated. N- 
Acetylglucosamine, the innermost residue linking heterosaccharide chains 
to the polypeptides, Is usually followed by a mannose residue(s). 
Branching of the chain may take place at this point or at subsequent
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residues. Mannose is again followed by N-acetylglucosamlne and this 
sequence may be repeated again. Galactose Is subsequently attached to 
an N-acetylglucosamlne residue, usually at the terminal or penultimate 
position. L-Fucose and sialic acid, when present, always occupy the 
terminal position at the non-reducing end of the chain. Thus a general 
pattern of the sugar sequence In the oligosaccharide chains of most 
plasma glycoproteins can be depicted as:
Asn-(GlcNAc)-(Man)-(GicNAc)-(Gal)-(slalic acid or L-fucose).
Although the structure of each carbohydrate moiety of a given 
glycoprotein Is relatively specific, variations In carbohydrate structure 
have been found even between molecules having the same amino acid 
sequences In the polypeptide portion. Thus the composition of a single 
oligosaccharide prosthetic group of ovalbumin Is not Identical In all 
ovalbumin molecules; the ratio of two sugar constituents, mannose and N- 
acetylglucosamine, have been reported to vary from 2.6 to 1.1 (114). In 
bovine pancreatic rlbonuclease B, mannose and N-acetylglucosamlne were 
found In ratios varying from 2.5 to 3.0 (115). This type of "peripheral 
microheterogeneity," caused by variations In the peripheral residues, has 
been reported for oi-acld glycoprotein (116), fetuin (117), a2 -macro- 
globulln (118), transferrin (119) and most other glycoproteins studies. 
"Central heterogeneity" Is found In IgG (120), where one heterosaccharide 
Is linked by N-acetylglucosamlne to an asparagine residue and another by 
N-acetylgalactosamlne to a threonine residue. Myeloma globulin A has 
three distinct heterosaccharides, two linked to asparagine and one to 
serine (121). Similarly, thyroglobulln has been found to contain two 
different types of heterosaccharide units (122).
16
The physiological or pathological significance of "peripheral" 
or "central" microheterogeneity Is not known as yet but certainly de­
serves further consideration and careful study.
Biological Role of the Carbohydrate Moiety of Glycoproteins
A simple protein owes Its specificity and structural complexity 
to the kind, number and sequence of amino acids that make up Its poly­
peptide chaln(s). A glycoprotein supersedes simple proteins In these 
properties by virtue of Its additional carbohydrate side chains which 
provide means for further specificity and diversification. The presence 
of negatively charged slallc acid and the relatively more lipophilic 
L-fucose residues provides glycoproteins with additional opportunities 
for Interactions with other macromolecules, especially In membranes; 
consequently, glycoproteins should be capable of carrying on more 
specific and versatile functions than simple proteins.
Glycoproteins Indeed participate In a wide variety of reactions 
such as blood-clotting, antigen-antibody Interactions, freezing-point 
depression, regulation of organ growth, and metal and hormonal transport. 
They also serve as virus receptors, act as lubricants, filtration barriers 
and supportive elements and provide protection from proteolytic enzymes 
(123-125). The antigenic activities of A, B, H and Lewis blood group 
substances are certainly manifestations of the structure of their 
heterosaccharide chains (126). Pazur et al. (127) have proposed that 
the carbohydrate moieties stabilize the three-dimensional structure of 
some glycoenzymes and In turn Influence their catalytic activities.
Since most glycoproteins are exported from the cells In which 
they are synthesized, Eylar (128) has suggested that the carbohydrate
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portion of glycoproteins may take part in the process of transport by 
interacting with cell membranes and thus facilitating secretion. This 
interaction may also help in the reverse process when glycoproteins enter 
cells. Kukral et al. (129) observed that the appearance of radioactivity 
in the liver following intravenous injections of ^^^I-labeled haptoglobin 
into dogs was dependent on the content of sialic acid in the haptoglobin 
molecule. Unmodified haptoglobin penetrated more freely into extravas- 
cular spaces and was excreted more easily from the body than asialo- 
haptoglobin. These observations seem to be in agreement with Eylar's 
hypothesis. Not all secreted proteins are glycoproteins, however.
Albumin and insulin are good examples of proteins which lack carbohydrate 
side chains and are secreted in large quantities. Therefore, Eylar's 
hypothesis does not seem to be applicable to all exportable proteins.
Another, better-documented role for the carbohydrate moiety 
appears to be in the protection of the glycoprotein molecule from diges­
tion by proteolytic enzymes. Morell and coworkers (130) have found that 
desialyzed plasma proteins including orosomucoid, fetuin, ceruloplasmin, 
haptoglobin, a2 ~macroglobulin, and thyroglobulin are more promptly 
removed from circulation and degraded in the liver than are their normal 
counterparts. Similarly, ammonium sulfate-fractionated fetuin is re­
sistant to digestion by trypsin and a-chymotrypsin until sialic acid is 
first removed (131).
One approach for elucidating the exact role of the carbohydrate 
portion of a glycoprotein molecule involves the stepwise removal of its 
sugar residues to see the impact of this treatment on the biological 
activity of the protein. Removal of sialic acid results in complete
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loss of biological activity of erythropoietin, human chorionic gonado­
tropin and follicle stimulating hormone (126). Its presence is also 
necessary for antigenic activity of M and N blood group substances (132). 
Similarly, removal of 94% of the sialic acid from human luteinizing 
hormone leads to a marked loss in biological activity (133). The intact 
carbohydrate moiety of fibrinogen is essential for its role in blood- 
clotting, and patients suffering from dysfibrinogenemia, caused by a 
deterioration of the carbohydrate moiety of fibrinogen, encounter 
difficulties in blood coagulation (113). On the other hand, activities 
of certain enzymes such as serum cholinesterase and glutamyltranspeptidase 
are unchanged after removal of sialic acid (126). Little progress has 
been made in studying the biological role of other sugars because of the 
difficulties involved in their selective and complete removal from the 
remainder of the molecule.
This "stepwise removal" approach, however, is tantamount to 
studying the function of a few amino acids that make up the "active 
center" of an enzyme and assuming that the rest of the molecule is with­
out any function. In view of the qualitative and quantitative differences 
found in the content and pattern of heterosaccharide units present in a 
wide variety of glycoproteins participating in many different types of 
reactions, it will be difficult to assign a common role to their 
carbohydrate moieties. It may be more reasonable to assume that in many 
respects heterosaccharides are like the structural amino acids and per­
haps, to some extent, help in shaping and maintaining the conformation 
of a glycoprotein molecule.
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Biosynthesis of Glycoproteins
Sites of Plasma Protein Synthesis 
The involvement of the liver in the production of plasma pro­
teins has been recognized for a long time. The earlier work in this area 
has been reviewed by Madden and Whipple (134) . A decrease in serum pro­
teins after partial hepatectomy (52), impairment of plasma protein 
synthesis following the administration of hepatic poisons (135-136), and 
a considerable reduction or abolition of the stress-induced increases in 
glycoprotein response after partial hepatectomy (137) provided evidence 
supporting the liver as the major site of plasma protein synthesis.
The elegant work of Miller and coworkers (138) on the incorpo­
ration of radioactive amino acids into serum proteins by the isolated, 
perfused rat liver clearly demonstrated the dominant role of this organ 
in serum protein synthesis. The synthesis of all plasma proteins 
(except the immunoglobulins) by the liver is now well documented (139). 
Simkin and Jamieson (140) have studied the in vitro synthesis of serum 
glycoproteins in liver slices and liver microsomes and have proved that 
labeled amino acid and sugar precursors can be incorporated into an 
a-globulin fraction which can be liberated by ultrasonic treatment and 
precipitated with a specific antiserum to a-globulins.
Synthesis of the Protein Moiety 
The synthesis of the polypeptide chains of glycoproteins takes 
place on polysomes in the conventional manner. Introduction of some im­
proved methods for the fractionation of polysomes into free and membrane- 
bound species (141, 142) has greatly facilitated work on the functional
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differentiation between various populations of polysomes. Evidence in 
favor of the view that membrane-bound and free polysomes synthesize two 
different families of proteins is gradually increasing. A number of 
studies indicate that the majority of proteins destined to be exported 
from the cell are synthesized by membrane-bound polysomes, while non­
exportable, intracellular proteins are mainly synthesized by free poly­
somes. Thus Redman (143) has reported that while most of the serum 
proteins are synthesized on membrane-bound polysomes, ferritin, a non­
exportable protein, is preferentially synthesized on free polysomes. 
Similarly, Hick et al. (144) have concluded that albumin is synthesized 
largely on membrane-bound polysomes, whereas ferritin is primarily 
synthesized on free polysomes. Ogata and coworkers (145) have carried 
out in vitro syntheses of serum proteins on isolated free and bound 
polysomes and by using a specific antiserum have proved that albumin is 
synthesized exclusively on membrane-bound polysomes. Recent studies by 
Glaumann (146) indicate that albumin is synthesized on ribosomes attached 
to the rough endoplasmic reticulum (RER) and is then transported out of 
the cell via the smooth endoplasmic reticulum (SER) and the Golgi com­
plex. Sherr and Uhr (147) have found that IgG is also largely synthesized 
on membrane-bound polysomes. The same is true for 3-lactoglobulin syn­
thesis in the mammary gland (148).
The concept of functional differentiation and division of 
labor with respect to protein synthesis poses an obvious question as to 
how the cell benefits from such a mechanism. The attachment of poly­
somes to the membranes may offer a number of advantages to the cell (149). 
The transport of proteins synthesized on these polysomes may be greatly
21
facilitated. The differential synthesis of some proteins on membrane- 
bound polysomes and that of others on membrane-free polysomes may assist 
the cell in making a distinction between proteins to be secreted from the 
cell and those to be retained inside. The attachment of polypeptides, 
synthesized on membrane-bound polysomes, to the membranes may also facili­
tate the association of the subunits of a protein. Tata (150) has sug­
gested that another role for ribosome-membrane association may be to 
achieve a "topographical segregation" of different groups of ribosomes 
synthesizing different types of proteins. It has also been suggested that 
the membranes to which ribosomes are attached may serve to protect mRNA 
and/or ribosomes from rapid degradation (151).
In accordance with the "functional differentiation" concept, 
the biosynthesis of plasma glycoproteins would be an exclusive function 
of membrane-bound polysomes. Substantial evidence indicates that this 
indeed is true for a number of glycoproteins studied so far (143, 152- 
154).
The stress-induced increase in the rate of labeled amino acid 
incorporation into plasma proteins and liver proteins has been observed 
both in vivo (155, 156) and in vitro (157-159). Both the microsomes, as 
well as the cell sap, from the stressed animals showed a higher activity 
than those from normal controls, but the microsomes were considerably 
more active than the cell sap (160). Maximum stimulation was obtained
18-24 hours after injury. Since the response to trauma was abolished by
puromycin or actinomycin D when administered at the time of injuiry. 
Chandler and Neuhaus (161) suggested that the increase in serum proteins
in response to stress was a consequence of an increase in mRNA, possibly
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due to an Increase in its rate of synthesis. A similar two to three-fold 
increase in amino acid incorporating ability of microsomes and ribosomes 
isolated from the regenerating liver has been observed by a number of 
investigators (162-166) with a maximum at 40-48 hours following operation.
Thus, a marked increase in the activities of polysomes isolated 
from livers of animals subjected to injury and partial hepatectomy seems 
to be well documented. Whether this increase in activity is a property 
of membrane-bound polysomes, or free polysomes, or both, still remains to 
be investigated.
Synthesis of the Carbohydrate Moiety 
In contrast to the nucleic acid-directed synthesis of the poly­
peptide backbone, the synthesis of the oligosaccharide units of glyco­
proteins is directed only by enzymes. Research in the area of glyco­
protein biosynthesis has made considerable progress during the last 
decade and most of this work has been discussed recently in a number of 
review articles (58, 139, 167-173).
Initial work on the incorporation of labeled sugar precursors 
into serum glycoproteins using whole animals (174, 175), isolated, 
perfused livers (176, 177) and tissue slices (178, 179) led to the 
identification of the endoplasmic reticulum (microsomes) as the sub- 
cellular site of glycosylation (180-182). Most of the sugars added were 
recovered in the deoxycholate-soluble fractions of liver microsomes, 
including the RER and SER (183). Simkin and Jamieson (184) injected 
labeled leucine and glucosamine into guinea-pigs and recovered the label 
in an a-globulin fraction released from the liver microsomes by ultra­
sonic treatment. Similar results were obtained when they studied the
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in vitro incorporation of N-acetylglucosamine into protein material of 
isolated liver microsomes (185-186). They noticed, however, that the 
heterosaccharide units of glycoproteins synthesized in vitro were incom­
plete. The terminal sialic acid residues in particular were lacking.
Li, et al. (187) isolated two radioactive glycopeptides from a 
deoxycholate-soluble fraction of rat liver microsomes which were rich in 
glucosamine and mannose, but contained little galactose or sialic acid. 
Based on these findings they concluded that it was primarily the inner 
cores of the heterosaccharide chains which are synthesized in the micro­
somes. Lawford and Schachter (153) have presented evidence indicating 
that the addition of the initial glucosamine residues occurs while the 
polypeptide chains are being synthesized on membrane-bound polysomes. 
Further hexosamine residues are added while the polypeptides traverse 
the channels of the RER and SER on their way out of the cell. Sialic 
acid is added at the final stages of this synthetic process. Kern and 
coworkers (188-190) have studied the incorporation of labeled amino acid 
and sugar precursors into immunoglobulins by lymph node cells and have 
also concluded that microsomes are the primary site of glycoprotein 
synthesis. The same conclusions have been drawn by Uhr and coworkers 
(191, 192) from their work on immunoglobulin synthesis by mouse nyeloma 
cells. Both Kem and colleagues and Uhr and coworkers have suggested 
that the initial glucosamine residues are added to the nascent poly­
peptide chains, while galactose and subsequent glucosamine residues are 
added after the chains are released from the ribosomes. The consensus 
of opinion now seems to favor the view that the first glucosamine residue 
is attached to the polypeptide as it is being synthesized and while it is
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still attached to the polyribosomes (193-196) .
The monosaccharides are not incorporated directly into glyco­
proteins as such, but are first converted to activated intermediates in 
the form of sugar nucleotides which act as sugar donors in the enzymatic 
process of heterosaccharide chain elongation (139, 197). Such inter­
mediates, synthesized in vivo from glucose, include UDP-N-acetylglucosa- 
mine, UDP-N-acetylgalactosamine, UDP-glucose, UDP-galactose, GDP-mannose, 
GDP- fucose, and CMP-sialic acid. The use of these activated monosac­
charides in in vitro systems has permitted the identification and 
characterization of various glycosyltransferases bound to the membranes 
of the ER (172, 198-206). These enzymes exhibit marked specificities 
and each monosaccharide is transferred to the growing oligosaccharide 
chain by a separate transferase. Consequently, there should be at least 
one and possibly more than one enzyme (to account for positional speci­
ficity) for each sugar found in the carbohydrate moieties of various 
glycoproteins.
Another contribution that made further localization of glycosyl­
transferases possible was Dallner's introduction of an improved method 
for the subfractionation of microsomes into rough and smooth forms (207, 
208). The use of this method by a number of investigators (209-220) has 
resulted in the identification of glucosaminyl- and mannosyltransferase 
activities in the rough and glucosaminyl- and galactosyltransferase 
activities in the smooth microsomes.
Recent progress in the methodology of isolating intact Golgi 
membranes (221-225) has revealed that in these organelles most of the 
peripheral sugar residues are added, and the synthesis of glycoprotein
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molecules completed, before secretion. The Golgi membranes contain 
glucosaminyl-, galactosyl-, fucosyl-, and sialyltransferase activities 
(226-230), but little or no mannosyltransferase activity has been de­
tected.
Many of these membrane-bound transferases have been solubilized 
and purified several-fold and the optimal conditions for their maximal 
activity have been settled in a number of cases (231-240). In addition 
to unfinished endogenous glycoproteins, the enzymes can also utilize 
exogenous glycoproteins as their substrates, provided a suitable number 
of sugar residues is first removed sequentially from the non-reducing 
end of the oligosaccharide chains (227, 231).
Several lines of evidence (241-245) indicate that the in vivo 
transfer of monosaccharides from sugar nucleotides to the endogenous 
glycoprotein acceptors involves lipid intermediates. Since the sugar 
nucleotides are present in the aqueous cytoplasm, whereas glycoproteins 
undergoing synthesis are bound to and transported through the lipid- 
containing membranes of the ER, the idea of an intermediate synthesis of 
glycolipids capable of transferring sugar residues from a hydrophilic to 
a hydrophobic environment seems to be highly attractive. Although in­
corporation of monosaccharides into glycolipids is well documented 
(241-245) the nature and function of these intermediates is still an 
open question. Consequently, more work needs to be done to support the 
"lipid intermediate hypothesis" in the biosynthesis of glycoproteins.
In the light of the evidence currently available, the following 
general scheme for the biosynthesis of glycoproteins can be visualized.
The apoprotein part of a glycoprotein molecule is synthesized
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on membrane-bound polysomes by the conventional template mechanism of 
protein synthesis. As soon as the polypeptide chains accumulate suffi­
cient amino acids to acquire a particular conformation recognizable by a 
transferase, the initiation of glycosylation can occur with the addition 
of the innermost N-acetylglucosamine residue while the polypeptide is 
still bound to the ribosomes. This is followed by the addition of 
mannose residues which could either take place immediately before, or 
more probably after, the release of the polypeptide from polysomes. 
Subsequent addition of mannose and N-acetylglucosamine residues results 
in the formation of a branched oligosaccharide core. The addition of a 
few more mannose and subsequent N-acetylglucosamine residues continues as 
the incomplete glycoprotein molecules migrate through the membranes of 
the SER towards the Golgi complex. The addition of galactose might start 
in the membranes of the SER, but most of the peripheral sugars including 
N-acetylglucosamine, galactose, fucose and sialic acid seem to be largely 
incorporated in the membranes of the Golgi complex. There is no clear 
line of demarcation between membranes of the SER and the Golgi complex.
In fact, the Golgi complex may be considered an extension and a deriva­
tive of the SER. Thus some of the enzymatic activities are shared by 
both, but are apparently concentrated in the Golgi complex. The addition 
of the peripheral sugars, galactose and sialic acid or fucose, completes 
the synthesis of the carbohydrate side chains and the completed glyco­
protein is now enclosed by a Golgi-derived membrane to form a vesicle.
This vesicle then migrates, or is transported, through the cytoplasm to 
the plasma membrane. At this point the vesicular membrane and the plasma 
membrane merge, releasing the contents of the vesicle to the extracellular
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environment.
This scheme of sequential addition of different sugars at 
different subcellular sites, which is largely based on in vitro studies, 
is also supported by in vivo studies as revealed by radioautography 
(246, 247).
Aims and Objectives
The preceding discussion on the various aspects of glycoprotein 
synthesis permits the following conclusions: The alterations in the
levels of many plasma proteins in response to various types of physical 
and pathological stress seem to be a manifestation of the same general 
phenomenon. No matter how the stress stimulus is applied, the resultant 
increases in plasma levels of glycoproteins are strikingly similar. This 
is probably because these changes are produced by the same kind of 
mechanisms. Hormones are certainly important in inducing the stress 
response but their precise mechanism of action is still not clear.
Although the present state of knowledge of the biological role 
of individual plasma proteins still does not permit any reasonable evalu­
ation of the true significance of the changes observed after stress, 
recent progress in elucidating the mechanisms of glycoprotein biosynthe­
sis can serve as a basis for studying the mechanisms of their regulation
 an area equally important and interesting but not sufficiently
explored. An understanding of the mechanisms of glycoprotein regulation 
may lead to a better comprehension of the significance of the changes in 
the levels of individual plasma proteins. Most studies in this context 
have been centered around the regulation of the synthesis of the apo­
protein part of glycoproteins. Although the regulation of the polypeptide
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synthesis is, of course, very important, studies restricted to this 
portion only are incomplete and are open to many questions. For instance, 
is the synthesis of the carbohydrate moiety of glycoproteins also regu­
lated along with the protein moiety? Is there a concomitant increase 
in the synthesis of glycosyltransferases or are they already present in 
adequate amounts? Is there an increase in the membrane components of 
the cell to bind increased quantities of glycoproteins undergoing 
synthesis, or is the rate of glycoprotein transport in the cell enhanced? 
It was partly to answer these and other such questions that this work 
was undertaken.
Although stress in various forms has been shown to cause marked 
stimulation of monosaccharide incorporation into plasma proteins in vivo 
(248), no one has looked into the possibility of the regulation of the 
synthesis of oligosaccharide chains of glycoproteins at the subcellular 
or enzyme level. The successful demonstration by Bley and Chandler (249) 
that the enzyme responsible for the in vivo synthesis of glucosamine-6- 
phosphate (L-glutamine-D-fructose-6-phosphate aminotransferase) is 
induced after injury and partial hepatectomy prompted the undertaking 
of the present work on the regulation of glycoprotein synthesis at the 
level of glycosylation. The effects of injury and partial hepatectomy 
on the activities of glucosaminyl-, galactosyl-, and mannosyltransferase 
activities were studied and the results of these investigations are 
reported in this dissertation. Because of the growing evidence that 
there are functional differences between various populations of polysomes, 
a study on the effect of injury and partial hepatectomy on the activities 
and the distributions of membrane-free and membrane-bound polysomes was
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also undertaken and the results are reported in this work.
Injury and partial hepatectomy were selected as model systems 
for studying the regulation of glycoprotein biosynthesis throughout this 
work. Although the acute-phase response can be produced by a variety of 
treatments including experimental infection, scalding, subcutaneous 
injections of corrosive agents, and bone fractures, simple laparotomy 
was chosen because of its relative aseptic nature, reproducibility, 
semi-quantitative control and many other factors discussed by Chandler 
(250). Partial hepatectomy offered a different, more drastic, but 
similar model system; one which has been studied extensively except in 




Male albino rats, 50-60 days old, weighing from 225 to 250 g, 
were purchased from the Holtzman Company, Madison, Wisconsin. The 
animals were fed standard laboratory chow and water ad libitum for at 
least one week prior to use.
UDP-N-acetylglucosamine-l-l^c (42 mC/mmole); UDP-galactose- 
[D-galactose-l^C (U.L.)], (252 mC/mmole) ; GDP-mannose- ‘̂*0 [D-mannose-l^c 
(U.L.)], (155 mC/mmole) ; L-leucine-(U.L.), (255 mC/mmole) ; and L- 
phenylalanine-^^^C (U.L.), (366 mC/mmole) were purchased from New England 
Nuclear Corporation.
Unlabeled UDP-N-acetylglucosamine, ATP and GTP were obtained 
from Sigma Chemical Company, and UDP-galactose, GDP-mannose, phosphoenol- 
pyruvate and pyruvate kinase were purchased from Calbiochem.
"Ultrapure" sucrose, L-amino acids, and CsCl were purchased 
from Mann Research Laboratories. Dextran 500 was obtained from Pharmacia 
and Triton X-100, from Rohm and Haas. Fetal calf serum was purchased 
from GIBCO. Human plasma was obtained from the Oklahoma Medical Research 
Foundation (Cancer Section). Chromatographically-purified 3-galacto- 
sidase (E.coli) was purchased from Worthington Enzyme Corporation.
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Hepatectomies were performed by the method of Higgins and 
Anderson (251). Injuries were produced by laparotomy (sham hepatectomy). 
The procedure was that used for partial hepatectomy, but stopped short of 
the manipulation and ligation of the liver lobes.
Preparation of Liver Homogenates 
The animals were fasted for 18 to 20 hours prior to sacrifice 
in order to deplete the liver of its glycogen content. Injured animals 
were sacrificed 24 hours after surgery and partially hepatectomized 
animals 48 hours after surgery, except where indicated. The animals 
were anesthetized with ether and their livers were perfused in situ 
through the portal vein with 50 ml of 0.15 M ice-cold saline solution.
The livers were then removed, rinsed with a small portion of homogenizing 
medium, blotted on absorbent paper, weighed and put into 10 ml of ice- 
cold homogenizing medium. All further steps prior to incubation were 
carried out at 0-4° and all apparatus and solutions used thereafter were 
prechilled to 0-4°. The livers were minced with sharp scissors, trans­
ferred to a homogenizer, and the total volume of the homogenization 
medium was brought to 3 volumes (w/v).
Gentle homogenization was performed in a loose-fitting Potter- 
Elvehjem Teflon-glass tissue homogenizer (Arthur Thomas Co., Type C) at 
a speed of 1500 rpm, using four, complete up and down strokes for livers
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from control and Injured animals and six complete strokes for livers from 
partially hepatectomized animals. Livers from partially hepatectomized 
rats required longer homogenization to obtain adequate yields of sub­
cellular fractions. In most of the experiments, homogenates from 3-4 
livers removed from animals subjected to similar treatment were pooled to 
obtain sufficient amounts of the required fractions.
Isolation of Free and Bound Polysomes 
Free and membrane-bound polysomes were isolated according to 
the method of Blobel and Potter (252). Livers were homogenized in 0.25 M 
sucrose, buffered with 0.05 M Tris-maleate, pH 7.6, containing 0.005 M 
MgCl2 , and 0.025 M KCl (TMK). Postmitochondrial supernatants (5 ml) from 
pooled liver homogenates were layered on top of two-step discontinuous 
sucrose density gradients composed of 4 ml each of 0.5 M and 2.0 M suc­
rose. All sucrose solutions were buffered with TMK. The gradients were 
centrifuged at 40,000 rpm in an SW 40 Ti rotor for 24 hours. Free poly­
somes sedimented through the 2.0 M sucrose layer and were collected as a 
pellet. Membrane-bound polysomes formed a band at the interface between 
0.5 M and 2.0 M sucrose layers and were withdrawn with a pipette. Both 
free and bound polysomes were treated for 15-20 minutes with sodium 
deoxycholate and Triton X-100 (final concentrations 1% and 4%, respec­
tively) to eliminate contaminating membranes. The resulting polysomal 
suspensions were layered on top of the two-step gradient described above 
and centrifuged for another 24 hours. The supernatants were discarded 
and the pellets were rinsed and suspended in 0.05 M Tris-maleate, pH 7.0, 
to give a final concentration of 8-12 mg of protein per ml for use in the 
amino acid incorporation assays.
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Isolation of Total Microsomes 
Microsomes were isolated and fractionated by the method of 
Dallner (207), using 0.25 M sucrose buffered with 0.01 M Tris-maleate, 
pH 7.4, as the homogenization medium.
The homogenates were centrifuged at 10,000 x g for 10 minutes 
in a Sorvall RC-2B refrigerated centrifuge using an SS-34 rotor and 50 
ml capacity polypropylene centrifuge tubes. The supernatant fluid was 
decanted and passed through four layers of cheese-cloth to remove lipids, 
and the postmitochondrial supernatant was centrifuged at 105,000 x g for 
60 minutes in a Beckman Ultracentrifuge using the 50-Ti rotor. The 
resulting supernatant was discarded and the surface of the microsomal 
pellet was rinsed carefully with 0.05 M Tris-maleate, pH 7.0. The 
pellets were gently resuspended in the same buffer with the help of a 
manually operated Teflon-glass homogenizer. The final volumes were 
adjusted to obtain a concentration of 15-20 mg protein per ml. These 
suspensions were used in the sugar incorporation assays.
Fractionation into Rough and Smooth Microsomes 
All sucrose solutions used in this procedure were buffered with 
0.01 M Tris-maleate, pH 7.4. The microsomal pellets obtained above were 
gently resuspended in 0.25 M sucrose and enough CsCl was added from a
1.5 M solution to give a final concentration of 15 mM. Six and one-half 
ml of this suspension was layered over 6.5 ml of 1.3 M sucrose, also made 
15 mM with respect to CsCl. The gradients were centrifuged in a 50-Ti 
rotor at 165,000 x g for 3 hours. Rough microsomes sedimented through 
the 1.3 M sucrose layer and were obtained as a pellet. Smooth microsomes 
were withdrawn carefully with a pipette from the interface between the
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two layers, diluted 1:1 with 0.25 M sucrose, and sedimented by centri­
fugation at 105,000 X g for 60 minutes. The pellets were suspended in
0.05 M Tris-maleate, pH 7.0, to give 16-32 mg of protein per ml buffer. 
These suspensions were used in the sugar incorporation assays.
Isolation of Golgi-Rich Fraction 
The Golgi-rich fractions were isolated by a modification of a 
method developed by Morré and coworkers (221). Since starved rats were 
reported to yield relatively poor preparations of Golgi fractions (253), 
unstarved rats were used to isolate these fractions. Livers were homoge­
nized in a medium consisting of 0.05 M Tris-maleate, pH 7.0, 0.5 M 
sucrose, 1% dextran, and 0.005 M MgCl2 . Homogenates from 4-5 animals
were pooled and centrifuged at 1,500 x g for 15 minutes in a Sorvall
refrigerated centrifuge to sediment the cell debris and most of the 
nuclei. The pellets were discarded and the supernatants, carefully 
removed by décantation, were centrifuged again at 5,000 x g for 20 
minutes. This time the supernatants were discarded and the pellets were 
gently homogenized into 5 ml of 1.5 M sucrose. The suspensions were 
transferred to 33 ml capacity cellulose nitrate-tubes. Discontinuous 
gradients were made by layering 15 ml of 1.25 M sucrose over the sus­
pensions and then 12 ml of 0.5 M sucrose on the top. All sucrose 
solutions were prepared in a mixture consisting of 0.05 M Tris-maleate, 
pH 7.0, 1.0% Dextran 500 and 0.005 M MgCl^. The gradients were centri­
fuged in an SW 25.1 rotor at 25,000 rpm for 150 minutes using a Beckmen 
Model L2-65B ultracentrifuge. The Golgi membranes formed a cream-colored 
band at the interface between the 1.25 M and 0.5 M sucrose layers.
These were withdrawn by means of a Beckman Fraction Recovery System.
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After diluting 1:1 with 0.15 M saline solution the Golgi fractions were 
sedimented by centrifugation at 105,000 x g for 60 minutes. In order 
to reduce contamination of the fractions by plasma membranes and endo­
plasmic reticulum, the pellets were resuspended in the homogenization 
medium and sedimented at 2,000 x g. This step was repeated 2-3 times.
The final pellets were carefully rinsed with 0.05 M Tris-maleate, pH 7.0, 
and were suspended in the same buffer to a final concentration of 2-6 mg 
protein per ml. These suspensions were used in the sugar incorporation 
assays.
Incorporation of Amino Acids into Polysomes 
The incubation mixture for amino acid incorporation assays 
contained 175 ymoles of Tris-maleate, pH 7.4; 0.25 pmoles of GTP; 1.0
y mole of ATP; 10 ymoles of phosphoenolpyruvate; 100 yg of pyruvate
kinase; 35 ymoles of KCl; 2.0 ymoles of MgCl2 ; 0.2 ymoles of a mixture 
of 18 L-amino acids; 0.5 yC of L-leucine-^^C; 0.5 yC of L-phenylalanine- 
0.25 ml of polysomal suspension containing 2-5 mg of protein; and 
0.5 ml of the cell sap, in a total volume of 1.0 ml. The mixtures were
incubated for 30 minutes at 37° and precipitated by the addition of 3 ml
cold 5% TCA solution. These samples were stored overnight at 0-4° to 
effect complete precipitation of protein. The protein precipitates were 
heated for 10 minutes at 90° in 5% TCA to release non-protein-bound 
label, cooled, centrifuged in a clinical centrifuge, and processed for 
liquid scintillation counting.
Incorporation of Monosaccharides into Microsomal Fractions
Incubation mixtures for the in vitro incorporation of sugars
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contained, in a total volume of 100 pi, 0.5 pmoles of Tris-maleate, pH 
7.0; 1 pmole of MnCl2 ; 0.5 pmoles of MgCl2 ; 0.1 pmole of KCl; 0.5 pmoles 
of EDTA; Triton X-100 to a final concentration of 1%, where indicated; 
20,000 cpm of sugar nucleotide, labeled with *̂*0 in the sugar moiety;
0.2 pmoles of two other unlabeled sugar nucleotides, where indicated; 
and 40-60 pi of microsomal suspension containing 0.8-1.5 mg of protein. 
Assays were carried out in 15 ml capacity clinical centrifuge tubes in 
a shaking water bath at 37° for one hour. The reactions were stopped by 
the addition of 3 ml of ice-cold 5% TCA or 3 ml of 5% phosphotungstic 
acid solution in 2 N HCl and the samples were stored overnight to effect 
complete precipitation of protein. The tubes were heated at 90° for 10 
minutes to release labeled sugars not actually incorporated into protein. 
The samples were cooled and protein precipitates were collected by cen­
trifugation in a clinical centrifuge and processed for counting.
Incorporation of Monosaccharides into Golgi-Rich Fractions
The complete incubation mixture for monosaccharide incorpora­
tion into Golgi-rich fractions contained, in a total volume of 100 pi,
4 pmoles of Tris-maleate, pH 7.0; 1.0 pmole of tfaCl2 ; 0.5 pmoles of 
MgCl2 ; 0.5 pmoles of EDTA; Triton X-100 to a final concentration of 1%, 
where indicated; 20,000 cpm of the ^^C-labeled sugar nucleotide; 0.2 
pmoles of two other unlabeled sugar nucleotides, where indicated; and 
40-60 pi of Golgi suspension containing 0.2-0.6 mg protein. Incubations 
were carried out as described in the previous section.
Preparation of Samples for Liquid Scintillation Counting
The protein precipitates were washed 3 times each with 3 ml of
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cold 5% TCA or phosphotungstic acid solution and once with 3 ml of 95% 
ethanol. The pellets were then extracted with 3 ml of chloroform-methanol 
(2:1) and finally washed with 3 ml of diethyl ether, dried and dissolved 
in 2 ml of 0.2 N NaOH by warming to 80° in a water bath. A measured 
portion of the NaOH solution was removed for determination of protein 
content and that remaining was digested overnight with 0.5 ml of Hyamine 
hydroxide in scintillation vials placed in a 55° water bath. The digested 
samples were mixed with 10-12 ml of the "XDC" scintillation mixture of 
Bruno and Christian (254) and were counted in a liquid scintillation 
counter. All samples were corrected to 100% efficiency by the use of 
internal or external standards.
Extraction of Glycolipids 
The TCA precipitates obtained at the end of the reaction, as 
described above, were washed 3 times each with 3 ml of cold 5% TCA solu­
tion and once with 3 ml of 95% ethanol. The pellets were then extracted 
twice each with 5 ml of chloroform-methanol (2:1) for 15 minutes. The 
extracts were combined and washed with 0.15 M saline solution, dried in 
a stream of hot air and counted directly as described above.
Galactosyltransferase (Lactosamine Synthetase) Assay 
Galactosyltransferase activities were measured by the method 
of Babad and Hassid (255). Liver homogenates were diluted 10-fold with 
0.5% Triton X-100 and filtered through four layers of cheese-cloth. One- 
tenth ml of filtrate was used in each assay. The assay mixture contained 
4 pmoles of Tris-maleate, pH 7.0; 0.5 pmoles of MgCl2; 1.0 pmole of 
MnCl2 ; 2 pmoles of mercaptoethanol; 1 pmole of N-acetylglucosamine;
0.3-0.6 mg of enzyme protein, and 12,000 cpm of UDP-galactose-^^C in a
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total volume of 0.15 ml. Incubations were carried out in a 37° shaking 
water bath and the reactions were stopped after 5 minutes by adding 20 pi 
of 0.25 M EDTA neutralized with NaOH. These mixtures were applied to
1.5 ml (6 cm X 0.6 cm) columns of AG1-X2 resin (200-400 mesh, chloride 
form) prepared in distilled water. N-acetyllactosamine was eluted from 
the columns by 3 x 0.5 ml washes of distilled water and collected in 
scintillation vials. After adding 12 ml of the scintillation mixture, the 
samples were counted directly. All assays were corrected for the non­
specific hydrolysis of UDP-galactose-^‘C by hydrolases present in the 
homogenates. This correction was obtained by incubating and processing 
duplicate reaction mixtures in which N-acetylglucosamine was omitted.
The counts released as pure galactose were then subtracted from the total 
counts obtained from the corresponding complete reaction mixture.
Electron Microscopy
Golgi pellets were fixed for one hour in 2% glutaraldehyde in 
0.1 M cacodylate buffer, pH 7.2, at 4° and left overnight in the buffer. 
The samples were rinsed and postfixed for two hours in 1% OsO^ in 0.1 M 
cacodylate buffer, pH 7.2, at 4°. Dehydration was carried out in a graded 
series of ethanol concentrations, followed by propylene oxide. Specimens 
were embedded in Maraglas and silver sections were cut with a diamond 
knife on a Porter-Blum MT-1 microtome. The sections were mounted on 
uncoated copper grids and were stained with saturated, acidic uranyl 
acetate at 60° for 15 minutes followed by lead citrate for 8 minutes at 
room temperature. Electron micrographs were obtained with an RCA-EMÜ 3F 
electron microscope operated at 50 kv.
Liver cells were fixed and examined in exactly the same manner
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except that primary fixation was performed in 4% glutaraldehyde.
Analytical Procedures 
Protein was precipitated with 5% TCA solution, washed with 
ethanol and finally with ether. The precipitates were dissolved in 0.2 N 
NaOH and protein was determined by the method of Lowry et al. (256), or 
by the method of Gornall et al. (257), using bovine serum albumin as the 
standard. Ribonucleic acid was determined by the method of Schmidt and 
Thannhauser as modified by Munro and Fleck (258). Deoxyribonucleic acid 
(DNA) was determined by the method of Burton (259). Phosphorus was meas­
ured according to the method of Fiske and SufabaRow (260). Phosphorus 
readings were multiplied by 25 to obtain the amount of phospholipids.
Statistical Analysis 
Whenever possible and appropriate, statistical analyses were 
carried out on paired observations using the standard two-sided "student's 
Jt test." Paired comparisons (i.e., control and experimental observations 
obtained in the same experiments were considered paired) were employed 
because of large variations observed between individual sets of experi­
ments. In other instances, where appropriate and valid, comparisons 
were based on group analysis.
Differences between two values were considered significant 
only if the P values were less than 0.05.
CHAPTER III
RESULTS
Effects of Injury and Partial Hepatectomy on 
Membrane-Bound and Free Polysomes
Injury and partial hepatectomy stimulate hepatic RNA synthesis 
and result in a shift in the polysomal profiles towards heavier aggre­
gates. It has been suggested that these changes are indicative of an in­
crease in the rate of polysome formation (160). Since injury also stimu­
lates glycoprotein synthesis, which is primarily a function of membrane- 
bound polysomes (152-154), an increase in the population of liver 
polysomes as a result of injury should be reflected mainly or solely in 
the membrane-bound polysomes. The amount of free polysomes, on the other 
hand, may or may not be changed to any significant extent since the syn­
thesis of most non-exportable, intracellular proteins does not seem to be 
stimulated by stress as much as that of secretory proteins. Consequently, 
the ratio of membrane-bound to free polysomes in the liver should be 
significantly increased in stressed animals. In the regenerating liver, 
however, there is an increase in the rate of synthesis of intracellular 
proteins as well as of exportable, extracellular proteins, and, therefore, 
one might expect a different picture. The results of experiments designed 
to study the effects of injury and partial hepatectomy on the distribution 




EFFECT OF INJURY AND PARTIAL HEPATECTOMY ON THE 
RELATIVE DISTRIBUTION OF FREE AND MEMBRANE- 
BOUND POLYSOMES IN RAT LIVER
Polysomes Control Injury Partial Hepatectomy
Free Polysomes mg RNA/g liver
Mean ± s.e.m. 1.77 ± 0.06 1.51 ± 0.08 2.53 ± 0.16
No. of Observations 9 8 8
Difference (P) <0.02 <0.001
Bound Polysomes
Mean ± s.e.m. 0.97 ± 0.10 1.72 ± 0.11 0.93 ± 0.14
No. of Observations 9 8 8
Difference (P) <0.001 N.S.
Bound/Free Polysomes
Mean ± s.e.m. 0.55 ± 0.04 1.17 ± 0.04 0.36 ± 0.05
Difference (P) <0.001 <0.01
Polysomes were Isolated essentially as described in Methods, 
except that centrifugation was carried out in a 50 Ti rotor at 45,000 
rpm, and the pellets were suspended in distilled water for RNA deter­
minations .
Statistical analysis was based on non-paired comparison of 
groups. N.S. refers to "not significant."
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Injury caused a two-fold increase in the membrane-bound to free 
polysome ratio in the liver. This was due primarily to a marked increase 
in the amount of membrane-bound polysomes. At the same time there ap­
peared to be a small, but significant, decrease in the quantity of free 
polysomes.
Partial hepatectomy, on the other hand, resulted in a consid­
erable decrease in the ratio of membrane-bound to free polysomes due to 
an increase in the amount of free polysomes with little or no change in 
the quantity of membrane-bound polysomes. Because regenerating livers 
were subjected to longer periods of homogenization, the comparison of the 
absolute amounts of free and membrane-bound polysomes with those of con­
trol livers must be made with caution, and for this reason, the ratios 
of membrane-bound to free polysomes were considered to be a more reliable 
parameter.
Free and membrane-bound polysomes isolated from animals sub­
jected to injury or partial hepatectomy had amino acid incorporating 
abilities comparable to those isolated from normal controls (Table 2).
The incorporating abilities of free polysomes and bound polysomes were 
also equivalent. This is in agreement with the results of other investi­
gators (142, 261). Failure to detect an effect of injury or partial 
hepatectomy on the activity of the polysomes was surprising in the light 
of the findings of Liu and Neuhaus (160) and Majumdar et al. (54) that 
the amino acid incorporating ability of the microsomes and polysomal 
aggregation were increased following these treatments. The isolation of 
polysomes by the method of Blobel and Potter (141) required treatment 
with detergents like sodium deoxycholate and Triton X-100 to free the
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TABLE 2
EFFECT OF INJURY AND PARTIAL HEPATECTOMY ON 
CELL-FREE AMINO ACID INCORPORATION BY 
FREE AND MEMBRANE-BOUND POLYSOMES










Mean ± s.e.m. 2901 ± 836 3086 ± 843 3179 ± 879
Difference (P) N.S. N.S.
Bound Polysomes
1510 1106 1342





Mean ± s.e.m. 3009 ± 820 3386 ± 840 3132 ± 873
Difference (P) N.S. N.S.
The assays were carried out as described In Methods. The cell 
sap used In all Instances was derived from control livers In order to 
obtain a uniform effect of the supernatant factors.
Statistical analysis was based on paired observations; N.S. 
refers to "not significant."
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polysomes from the membranes. Blobel and Potter (262) and Ogata and 
coworkers (263) found that this treatment released rlbonuclease and caused 
marked degradation of polysomes to disomes and monosomes with a corres­
ponding decrease in amino acid incorporating ability.
Table 3 shows the results of an experiment designed to test the 
possibility that detergent treatment masked an increase in polysomal 
activity following injury and partial hepatectomy. It is clear that both 
free and membrane-bound polysomes isolated without detergent treatment 
exhibited an increase in amino acid incorporating ability after partial 
hepatectomy. This time the bound polysomes reached much lower specific 
activities than the free polysomes because of the high content of protein 
in the membranes. Treatment with detergents lowered the activities of 
the free polysomes drastically and brought all preparations to the same 
limiting value. Thus it appears that injury and partial hepatectomy did 
increase the protein synthesizing capacity of free and bound polysomes 
but this increase could not be detected because of the method used for 
their isolation. Another possible explanation could be that injury and 
partial hepatectomy caused an increase in the amounts of polysomes with­
out any significant change in their activity.
No appreciable differences were detected in the SNA to protein 
ratios of polysomes between control and experimental preparations (Table 
4). The SNA/protein ratio was slightly higher in free polysomes when 
compared to membrane-bound polysomes.
Effects of Injury and Partial Hepatectomy on Glycosylation 
Since microsomes are comprised of ribosomes, the sites of 
assembly of polypeptides, and of membranes, the location of many of the
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TABLE 3
EFFECT OF INJURY AND PARTIAL HEPATECTOMY ON CELL-FREE AMINO ACID 
INCORPORATION BY FREE AND MEMBRANE-BOUND POLYSOMES 
PREPARED WITH AND WITHOUT DETERGENT TREATMENT
Polysomes Control Injury Partial Hepatectomy
dpm/mg protein/30 min.
Free Polysomes
Without Detergent 158,085 163,947 243,429
With Detergent 18,278 17,218 28,783
Bound Polysomes
Without Detergent 19,946 25,428 28,456
With Detergent 18,933 18,728
The assays were carried out essentially as described in Methods. 
The polysomal preparations without detergent treatment were used one day 
following the sacrifice of the animals (24 hours centrifugation), while 
those with detergent treatment were used two days following the sacrifice 
of the animals (48 hours centrifugation). In this experiment a complete, 
tritiated amino acid mixture was used for incorporation. Each value 
represents the pooled livers of 4 animals in all cases.
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TABLE 4
EFFECT OF INJURY AND PARTIAL HEPATECTOMY ON 
BNA TO PROTEIN RATIOS OF POLYSOMES
Polysomes Control Injury Partial Hepatectomy
RNA/protein
Free Polysomes
Mean ± s.e.m. 0.78 ± 0.024 0.75 ± 0.027 0.78 ± 0.030
No. of Observations 10 10 10
Difference (P) N.S. N.S.
Bound Polysomes
Mean ± s.e.m. 0.66 ± 0.029 0.69 ± 0.024 0.64 ± 0.023
No. of Observations 11 11 11
Difference (P) N.S. N.S.
The differences between the RNA/protein ratios for free and 
membrane-bound polysomes were significant (p <0.005) for preparations 
from control and partially hepatectomized animals but not for injured 
animals.
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glycosyltransferases, it seemed logical to begin the study of the effects 
of injury and partial hepatectomy on the glycosylation process with this 
fraction. The glycosyltransferases studied were those for N-acetylglu- 
cosamine, galactose, and mannose.
Total Microsomes 
A significant increase in the incorporation of N-acetylglucosa- 
mine into the total microsomal fraction was seen after injury but not 
after partial hepatectomy (Table 5). The pattern of galactose incorpora­
tion into microsomes was similar to that for N-acetylglucosamine. Man­
nose incorporation, however, was much greater after partial hepatectomy 
(about 100%) than after injury (about 40%). It is interesting to note 
that the degree of stimulation caused by injury was about the same (40%) 
for all three sugars.
Postmicrosomal Fractions 
Reports by Wagner and Cynkin (209) and by Eylar (264) indicated 
that postmicrosomal particles, which are presumably derived from the SER 
(265), had much higher glucosaminyltransferase activities than microsomes. 
Accordingly, several experiments were performed to see if injury and 
partial hepatectomy had an effect on N-acetylglucosamine incorporation 
into postmicrosomal particles. The results of these experiments are 
shown in Table 6.
Injury had no effect, but partial hepatectomy resulted in a 
striking reduction in glucosamine incorporation into the postmicrosomal 
fraction. The significance of this reduction after partial hepatectomy 
is unknown. Although these results are presented on a mg protein basis
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TABLE 5
TRANSFER OF LABELED MONOSACCHARIDES FROM SUGAR NUCLEOTIDES
TO ENDOGENOUS GLYCOPROTEIN ACCEPTORS ASSOCIATED
WITH TOTAL MICROSOMES
Sugar Nucleotide Control Injury Partial Hepatectomy
dpm/mg protein/hour
156 282 194UDP-N-acetyl- 177 364 214
glucosamine-l^C 333 392 414
394 468 386
Mean ± s.e.m. 265 ± 68 377 ± 58 302 ± 57
Difference CP) — — <0.05 N.S.
207 376 398
GDP-mannos e-^ ̂ C 256 385 554
294 432 670
386 452 730
Mean ± s.e.m. 286 ± 38 411 ± 18 588 ± 73
Difference (P) <0.025 <0.025
304 417 293
UDP-galactos e-^^C 348 464 500
454 668 564
371 449 429
Mean ± s.e.m. 369 ± 32 500 ± 57 446 ± 58
Difference (P) --- <0.025 N.S.
Statistical analysis was performed on paired observations.
Each value represents pooled livers from 3-4 animals in all cases.
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TABLE 6
TRANSFER OF N-ACETYLGLUCOSAMINE-^FROM UDP-N- 
ACETYLGLUCOSAMINE-l^C TO ENDOGENOUS 
GLYCOPROTEIN ACCEPTORS ASSOCIATED 
WITH POSTMICROSOMAL FRACTIONS








Mean ± s.e.m. 1055 ± 191 1031 ± 209 437 ± 90
Difference (P) — —— N.S. <0.025
Postmicrosomal particles were prepared by the method of 
Siekevitz as modified by Wagner and Cynkin (209). Livers were homogenized 
in 2.3 volumes of a medium consisting of 0.35 M sucrose, 0.025 M KCl,
0.005 M MgCl2 , 0.005 M mercaptoethanol, and 0.05 M Tris maleate, pH 7.5. 
Nuclei, mitochondria and cell debris were removed by sedimentation at 
29,000 X g for 12 minutes. The supernatant was decanted and centrifuged 
at 105,000 X g for 40 minutes. The microsomal supernatant was withdrawn 
and the pellet was rinsed with 2 ml of homogenizing medium, with swirling, 
to remove the loose, gray material at the top. The supernatant and the 
rinsings were combined and centrifuged at 105,000 x g for 3 hours to 
yield the postmicrosomal pellet. After rinsing with 0.05 M Tris maleate, 
pH 7.0, the pellet was suspended in the same buffer and used in the 
assay.
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they should be considered with caution. The decrease seen after partial 
hepatectomy, for example, could result from differences in the sedimenta­
tion properties of the postmicrosomal particles or from their recovery 
by the swirling technique, rather than from a real change in enzyme 
activities.
Microsomal Subfractions
The successful demonstration of the stimulation of monosaccha­
ride incorporation into total microsomes by stress led to further work on 
tracing glycosyltransferase activities in the rough and smooth ER mem­
branes. The results summarized in Table 7 indicate that injury and 
partial hepatectomy had no significant effect on N-acetylglucosamine or 
galactose incorporation into rough microsomes. On the other hand, 
mannose incorporation into rough microsomes was increased two-fold after 
partial hepatectomy and, although not statistically significant, there 
seemed to be a consistent increase after injury as well.
With smooth microsomes, the situation was altogether different 
(Table 8). N-Acetylglucosamine incorporation was increased two-fold 
after injury, but partial hepatectomy had no effect. Again, galactose 
incorporation into the smooth microsomal fractions closely followed the 
pattern of N-acetylglucosamine incorporation. Mannose incorporation 
into these fractions was stimulated slightly both by injuiry and partial 
hepatectomy, but the latter was not statistically significant in these 
experiments.
Examination of Tables 7 and 8 also shows that smooth micro­
somes had much higher activities for N-acetylglucosamine and galactose 
incorporation than did rough microsomes, whereas the converse was true
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TABLE 7
TRANSFER OF LABELED MONOSACCHARIDES FROM SUGAR NUCLEOTIDES
TO ENDOGENOUS GLYCOPROTEIN ACCEPTORS ASSOCIATED
WITH ROUGH MICROSOMES






















Mean ± s.e.m. 131 + 14 146 ± 23 129 ± 19














Mean ± s.e.m. 203 + 39 304 ± 84 412 ± 67














Mean ± s.e.m. 106 ± 25 115 ± 37 116 ± 32
Difference (P) ———— N.S. N.S.
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TABLE 8
TRANSFER OF LABELED MONOSACCHARIDES FROM SUGAR NUCLEOTIDES
TO ENDOGENOUS GLYCOPROTEIN ACCEPTORS ASSOCIATED
WITH SMOOTH MICROSOMES














Mean ± s.e.m. 275 ± 30 525 ± 67 278 ± 28
Difference (P) —— — <0.01 N.S.
78 88 106
GDP-mannos e-l^c 76 108 13254 80 154
158 205 142
Mean ± s.e.m. 92 ± 23 120 ± 29 134 ± 10
Difference (P) -—— <0.05 N.S.
552 960 372
UDP-galactose-l^c 538 1354 732436 1354 378
478 883 467
Mean ± s.e.m. 501 ± 27 1138 ± 125 487 ± 84
Difference (P) <0.02 N.S.
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for mannose incorporation. These results contradict some previous re­
ports that showed rough microsomes to be more active in N-acetylglucosa­
mine incorporation than smooth microsomes (210, 216). These studies 
were, therefore, extended further to include the in vivo incorporation 
of glucosamine into microsomal fractions. The results are presented in 
Table 9. Smooth microsomes were again found to be 2-3 times as active 
as rough microsomes, supporting our in vitro results.
Ribonucleic Acid and Phospholipid Contents 
of Various Subcellular Fractions
The ENA and phospholipid contents of various cell fractions 
were determined to see if any changes were caused by injury or partial 
hepatectomy. The results are presented on a per mg protein and a per mg 
DNA basis in Table 10.
The only significant change observed was an increase in RNA 
after partial hepatectomy, reflected chiefly in those fractions contain­
ing rough microsomes. The phospholipid/protein ratio was also higher in 
total microsomes isolated from partially hepatectomized animals as 
compared to controls but examination of other subcellular fractions did 
not show any significant differences.
The high RNA and low phospholipid contents of the rough micro­
somes versus the low RNA and high phospholipid contents of the smooth 
microsomes are indicative of a good separation of the two fractions. 
Compared to many values reported in the literature the phospholipid/ 
protein ratios are high. This is because these fractions were thoroughly 
washed with TCA and organic solvents prior to determination of protein 
content. This treatment removed contaminating serum albumin, a factor
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TABLE 9
IN VIVO INCORPORATION OF GLUCOSAMINE-'^H INTO GLYCOPROTEINS 
OF MICROSOMAL SUBFRACTIONS







Mean ± s.e.m. 6,036 ± 41 5,100 ± 230 12,659 ± 362
Glucosamine-(10 pC/lOO g) was injected via the jugular vein 
and the animals were sacrificed one hour after injection. Microsomes 
were isolated and the radioactivity measured as described in Methods.
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TABLE 10
CHARACTERIZATION OF VARIOUS SUBCELLULAR FRACTIONS





0.057 ± 0.003(4) 
0.191 ± 0.007(7) 
0.315 ± 0.015(4) 
0.055 ± 0.013(4)
RNA/protein 
0.058 ± 0.003(4) 
N.S.
0.204 ± 0.009(7) 
N.S.
0.330 ± 0.017(4) 
N.S.
0.045 ± 0.007(4) 
N.S.
0.072 ± 0.004(4) 
P=0.O25 
0.307 ± 0.016(7) 
P<0.001 
0.410 ± 0.023(4) 
P<0.02 






0.200 ± 0.004(4) 
0.424 ± 0.010(4) 
0.285 ± 0.023(4) 
0.493 ± 0.026(4)
PL/protein 
0.210 ± 0.012(4) 
N.S.
0.472 ± 0.026(4) 
N.S.
0.315 ± 0.021(4) 
N.S.
0.513 ± 0.015(4) 
N.S.
0.200 + 0.004(4) 
N.S.
0.616 ± 0.020(4) 
P<0.001 
0.268 ± 0.029(4) 
N.S.
0.543 ± 0.033(4) 
N.S.
Liver Homogenate 4.465 ± 0.170(8)
RNA/DNA 
4.598 ± 0.200(8) 
N.S.
5.260 ± 0.180(8) 
P<0.01
Liver Homogenate 14.74 ± 1.12(4)
PL/DNA 
14.69 ± 0.96(4) 
N.S.
14.45 ± 0.58(4) 
N.S.
Values are expressed as mean ± s.e.m. The numbers in paren­
thesis refer to the number of observations. P=probability. PL=phospho- 
lipids.
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taken into account by only a few investigators (266). The values re­
ported here are in excellent agreement with those of Glauman and Dallner 
(267, 268).
Golgi-Rich Fractions
The Golgi fractions Isolated in these experiments exhibited 
very high glucosaminyl- and galactosyltransferase activities of the order 
of 20-30 times that exhibited by total microsomes or crude liver homoge- 
nates (Table 11). The specific activities of the transferases present in 
the Golgi-rich fractions may be used as rough estimate of the purity of 
these fractions (168). The values shown in Table 11 are in good agree­
ment with those reported by others (224-227). Injury or partial hepa­
tectomy caused no changes in the specific activities of glucosaminyl- or 
galactosyltransferases when compared to each other or to control values. 
These results indicate that the Golgi-rich fractions isolated from con­
trol, injured and partially hepatectomized animals had equal glycosyl­
transferase specific activities. It is possible, however, though 
unlikely, that the various Golgi-rich fractions had unequal transferase 
activities and were also of unequal purity so that fortuitously equal 
specific activities were obtained.
Electron microscopic examination of intact and isolated Golgi 
complexes was undertaken to see if injury or partial hepatectomy caused 
morphological changes in this organelle. Plates 1-3 show electron 
micrographs of portions of hepatocytes from control, injured and par­
tially hepatectomized animals. The appearance of typical stacks of 
parallel, flattened cistemae surrounded by vesicular profiles and 
secretory vesicles mark the Golgi apparatus. The elongated, flattened
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TABLE 11
TRANSFER OF LABELED MONOSACCHARIDES FROM SUGAR NUCLEOTIDES 
TO ENDOGENOUS GLYCOPROTEIN ACCEPTORS ASSOCIATED 
WITH GOLGI-RICH FRACTIONS




glucosamine-l^C 5765 7724 3305
Mean ± s.e.m. 7436 ± 882 8991 ± 1105 5913 ± 1381
Difference (P) — — N.S. N.S.
17071 19224 16826
UDP-galactos e-  ̂̂ C 21001 20824 21390
16825 25020 14596
Mean ± s.e.m. 18299 ± 1352 21688 ± 1728 17604 ± 1998
Difference (P) —— N.S. N.S.
Little or no mannosyltransferase activity was detected in 
Golgi-rich fractions.
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Plates 1-3. Thin sections of portions of liver cells showing 
Intact Golgi apparatl at high magnification (x 77,000).
Plates 4-9. Thin sections of isolated Golgi-rich fractions. 
Plates 4, 6 and 8 present a view at low magnification (x 33,500), and 
Plates 5, 7 and 9 present a view at high magnification (x 77,000).
Stacks of parallel, secretory vesicles and numerous vesicular 
profiles can be seen with occasional presence of lysosomes and some 
electron dense bodies. C, I, and H refer to preparations from control, 






sacs are sometimes dilated at the ends and contain small secretory vesi­
cles. Occasionally secretory vesicles are found connected to elongated 
tubules. There are no detectable differences in the morphology of the 
Golgi bodies of control and experimental liver cells.
Thin sections of Golgi-rich fractions isolated from control, 
injured and partially hepatectomized rats are shown in Plates 4-9.
Typical elements of the Golgi complex are found in abundance. These 
include cisternae, secretory vesicles and tubular profiles. The electron 
microscopic assessment indicates that the preparations were 70t80% pure. 
The main contaminants appeared to be plasma and SER membranes. Occasion­
ally, lysosomes, electron-dense bodies, and mitochondria were detected.
As with the whole cells there appeared to be no detectable morphological 
differences between control and experimental preparations.
Effect of Sugar Nucleotide Supplementation on Monosaccharide 
Incorporation into Microsomes and Golgi-Rich Fractions
Wagner and Cynkin (226) found that the incorporation of N- 
acetylglucosamine into Golgi membranes from normal rats was stimulated 
by the addition of unlabeled GDP-mannose to the reaction mixture. This 
work was extended to see if similar stimulatory effects on incorporation 
could be observed with mannose and galactose, as well as with N-acetyl­
glucosamine, into Golgi-rich and microsomal fractions derived from con­
trol, injured and partially hepatectomized animals.
The incorporation of monosaccharides was generally stimulated 
by the presence of other sugar nucleotides when these were added as 
supplements to the reaction mixture (Table 12). This was true for the 
three sugars tested in almost all fractions with the exception of
TABLE 12
INCORPORATION OF LABELED MONOSACCHARIDES INTO MICROSOMES AND GOLGI MEMBRANES: 
EFFECT OF SUGAR NUCLEOTIDE SUPPLEMENTATION
Sugar Nucleotide Cell Fraction Control Injury Partial hepatectomy
dpm/mg protein/hour
(-) (+) (-) (+) (-) (+)
UDP-N-acetyl— Total Microsomes 177 246 (39)* 364 452 (24) 214 321 (50)
glucosamine-l^C Rough Microsomes 184 178 (--) 200 227 (14) 150 151 (— )
GDP-mannose Smooth Microsomes 363 603 (66) 826 1453 (76) 389 878 (126)
UDP-galactose_ Golgi Membranes 6338 8897 (40) 9482 12316 (30) 4120 5224 (27)
UDP-galactose-l^C Total Microsomes 304 409 (35) 417 756 (81) 293 440 (50)
UDP-N-acetyl- Rough Microsomes 166 271 (63) 210 331 (58) 181 385 (113)
+ glucosamine Smooth Microsomes 478 1149 (140) 883 2991 (239) 467 1824 (291)
_GDP-mannose Golgi Membranes 37566 59652 (59) 29390 38179 (30) 22662 44912 (98)
GDP-mannos e- ̂ C Total Microsomes 207 284 (37) 376 517 (38) 398 599 (51)
UDP-N-acetyl- Rough Microsomes 285 458 (61) 491 599 (22) 492 545 (11)+ glucosamine Smooth Microsomes 178 217 (22) 205 245 (20) 142 228 (61)
UDP-galactos e_ Golgi Membranest
o\
(—)=Non—supplemented reaction mixture. (+)=Supplemented reaction mixture. 
* =Percent stimulation is indicated in parenthesis, 
t =Golgi membranes lack mannosyltransferase activity.
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N-acetylglucosamine incorporation into the rough microsomal fractions.
The stimulatory effect of the sugar nucleotides indicates that the 
process of heterosaccharide chain elongation in vitro can proceed farther 
than just one step. The addition of each sugar residue must, therefore, 
be occurring at the proper position in the sequence and with proper 
steriochemical specificities, otherwise additional monosaccharide label 
could not be incorporated. This would also imply that the in vitro 
incorporation of a monosaccharide is terminated probably because of the 
saturation of the available acceptor sites. The addition of another 
sugar gives rise to additional acceptor sites and, consequently, the 
incorporation of the first monosaccharide can proceed further.
The incorporation of N-acetylglucosamine was stimulated by 
supplementation with GDP-mannose and UDP-galactose. Since N-acetyl­
glucosamine is largely attached to mannose residues at the growing end 
of the oligosaccharide chains, this stimulation was probably primarily 
due to GDP-mannose. The stimulatory activity was concentrated mainly in 
the smooth microsomal fraction. A similar effect of supplementation with 
UDP-N-acetylglucosamine and GDP-mannose was seen with galactose incor­
poration into rough and smooth microsomes, except that here the stimula­
tion was greater than in the case of N-acetylglucosamine incorporation.
In this case, probably both of these sugars contribute to the stimulatory 
effect since both of them occupy a more internal position in the oligo­
saccharide chain than galactose.
The degree of stimulation of both N-acetylglucosamine and 
galactose incorporation into microsomes was significantly higher in the 
case of injury and partial hepatectomy than in the case of controls. A
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significant stimulation of N-acetylglucosamlne and galactose Incorpora­
tion was also observed In the Golgi-rlch fractions.
The Incorporation of mannose Into all microsomal fractions was 
significantly increased by supplementation with UDP-N-acetylglucosamlne 
and UDP-galactose but the stimulation was not as dramatic as In the case 
of the other two sugars.
Synthesis of Glycollpld Intermediates In the 
Biosynthesis of Glycoproteins
Several investigators have reported the transfer of sugars from 
their nucleotide derivatives to llpld acceptors In microsomal membranes 
(241-244), and they have suggested that these glycollplds may act as 
Intermediates In the biosynthesis of glycoproteins. Since Injury and 
partial hepatectomy stimulate glycoprotein synthesis (155-166), one might 
expect microsomal glycollpld synthesis to be stimulated as well, partic­
ularly If these glycollplds are Indeed precursors of glycoproteins. 
Furthermore, If the syntheses of glycollplds and glycoproteins are 
closely related to one another as suggested, then It should be possible 
to show a linear correlation between them following treatments that alter 
their synthetic rates. In several of the experiments previously described 
In which labeled monosaccharide transfer to glycoprotein material was 
measured, an organic-soluble fraction was routinely obtained as part of 
the work-up of the protein material. This organic-soluble material 
containing the glycollplds was processed further and counted as well. 
Several facts emerged from these data. First, all three sugars tested 
yielded organic-soluble, labeled material, assumed to be glycollplds 
(241-243). Second, Injury and partial hepatectomy Increased the amount 
of label Incorporated Into the organic-soluble material on a mg
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microsomal protein basis. Third, when the glycollpld counts, on a mg 
microsomal protein basis, were plotted In the form of a scattergram 
against their corresponding glycoprotein counts, also on a mg microsomal 
protein basis, good linear correlations were observed for all three 
sugars (Figures 1 and 2). Glucosamine and mannose Incorporation Into 
glycollplds was equivalent to about 10% of the counts Incorporated Into 
glycoproteins; for galactose. It was about 6%.
The results obtained here support the Idea that glycollplds are 
Intermediates In glycoprotein biosynthesis. It should be pointed out, 
however, that these results are only suggestive of such a relationship, 
since It Is equally probable that the syntheses of these two kinds of 
compounds could be simultaneously regulated In the same direction but 
not directly linked to one another.
Microsomal GlycosyItransferases ! Initial Rate Studies
The results of the previous experiments with microsomes clearly 
Indicated that Increases In the rate of monosaccharide attachment to 
endogenous glycoprotein acceptors following Injury or partial hepatectomy 
could be successfully demonstrated In vitro. These experiments, however, 
did not distinguish between rate Increases due to Increased endogenous 
acceptor concentrations and rate Increases due to stimulated enzyme 
activities or both. It has already been shown that stress can stimulate 
the synthesis of the apoprotein portion of glycoproteins (endogenous 
acceptors) (155-166), and also that of some sugar nucleotides (249, 269). 
Both of these act as direct substrates for glycosyltransferases and, 
therefore, the Increases observed In monosaccharide Incorporation In 
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Figure 1. Scattergram showing the correlation between the 
incorporation of mannose-^̂ Ĉ into glycoproteins and glycolipids of 
microsomal fractions isolated from livers of control, injured and 
partially hepatectomized rats.
Glycolipids and glycoproteins derived from the same samples 
of microsomes are plotted against each other.
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Figure 2. Scattergrams showing correlations between galactose-and 
glucosamine-incorporation into glycoproteins and glycolipids of microsomal fractions 
isolated from livers of control, injured and partially hepatectomized rats.
Glycolipids and glycoproteins derived from the same samples of microsomes are 
plotted against each other.
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on the basis of higher substrate concentrations alone. In the In vitro 
situation the concentration of sugar nucleotides can be controlled 
fairly well; thus, we are concerned only with the endogenous acceptor 
concentrations.
In an attempt to determine If the glycosyltransferases were 
Increased ("Induced") as well, a series of experiments were performed In 
which the Initial reaction rates of the glycosyltransferases were 
measured. The results are presented In Figures 3 and 4.
The Initial reaction rates of all three enzymes studied were 
consistently higher In microsomes Isolated from animals subjected to 
Injury or partial hepatectomy when compared to those Isolated from con­
trols. In the case of partial hepatectomy, mannosyltransferase activity 
was even higher than that seen after Injury. N-Acetylglucosamlnyl- and 
galactosyltransferase activities, however, were higher only during the 
Initial 2 minutes of the reaction, after which time there was no further 
Incorporation of N-acetylglucosamlne or galactose. These results can 
best be explained by assuming that at this point all the acceptor sites 
for these two sugars are saturated.
Figure 4 also shows the rate of mannose Incorporation Into 
glycollpld. Mannollpld synthesis was markedly stimulated both by Injury 
and partial hepatectomy. The Incorporation pattern was similar to that 
for glycoproteins except that the Incorporation Into mannollpld was 
greater after injury than after partial'hepatectomy. The Inverse was 
true for Incorporation Into glycoproteins.
Microsomal Glycosyltransferases; Use of Exogenous Acceptors 
The main difficulty encountered In the studies using the
GLUCOSAMINE-' C GALACTOSE -
10 o 0
MINUTES
Figure 3. Time course of incorporation of N-acetylglucosamine-^C and 
galactose-l^C into endogenous acceptors of total microsomes.
All assays were carried.out in the presence of 1% Triton X-100 and each 
point represents the results obtained from the pooled liver homogenates of 4 animals.
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Figure 4. Time course of incorporation of mannose-^‘*C into endogenous 
acceptors of total microsomes.
All assays were carried out in the presence of 1% Triton X-100 and each point 
represents the results obtained from the pooled liver homogenates of 4 animals.
Control; Injury ; Partial Hepatectomy.
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endogenous acceptors was that of the interpretation of the changes 
observed. Since the concentrations of the endogenous acceptors in these 
preparations could not be controlled, it was not possible to determine 
whether the increases in transglycosylation were due to increased enzyme 
activity or to increased acceptor concentrations or both.
Ai initial attempt to distinguish between these possibilities 
was carried out in the "initial rate" studies described above. The re­
sults obtained indicated, indirectly, that at least part of the increases 
occurred as a result of increased enzyme activity.
A more direct assessment of the actual changes in enzyme 
activities was made by using exogenous acceptors in the assay mixtures. 
The rationale behind these experiments was straightforward; if the 
endogenous acceptors are supplemented with a large excess of exogenous 
acceptors, the acceptor molecules should no longer be the rate-limiting 
factor in the assay. Any changes observed must, therefore, be the result 
of actual changes in enzyme activities or levels.
In the experiments described below, two kinds of exogenous 
acceptors were employed to measure changes in galactosyltransferase 
activities. The studies were restricted to galactosyltransferase for 
technical reasons; it is assumed that similar results would have been 
obtained for glucosaminyltransferase and probably for mannosyltrans feras e 
as well.
Lactosamine Synthetase (Galactosyltransferase)
Activities in Liver Homogenates
The measurement of lactosamine synthetase activity has been 
widely used to estimate the purity of Golgi preparations (223-225). This
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enzyme, which normally transfers galactose from UDP-galactose to N- 
acetylglucosamine residues present in the heterosaccharide side-chains 
of glycoproteins, can also use N-acetylglucosamine per se as a substrate, 
resulting in the synthesis of N-acetyllactosamine, The synthesis of the 
latter can be measured and serve as an indicator of galactosyltransferase 
activity. The results of several such experiments are summarized in 
Table 13. Each value represents results from liver homogenates pooled 
from three to four animals.
The activity of galactosyltransferase(s) was consistently and 
significantly increased (30%) following injury and partial hepatectomy.
Galactosyltransferase Activities of Liver Homogenates 
Assayed with Exogenous Glycoprotein Acceptors
Once the terminal sialic acid and galactose residues of a 
glycoprotein are removed it will act as an acceptor in the galactosyl­
transferase reaction. Two such exogenous acceptors were prepared from 
orosomucoid and from fetuin. (See Appendix for details for the prepara­
tion of these acceptors). Injury resulted in a 20-25% increase in 
galactosyltransferase activity when compared to controls, and partial 
hepatectomy resulted in a 38-48% increase (Table 14). Since this experi­
ment was performed one day after injury as well as one day after partial 
hepatectomy, injury can be used as a control for partial hepatectomy, 
which gives an increase of 1 0-2 0% due to partial hepatectomy alone.
The incorporation of galactose into exogenous acceptors was 
about 5 times higher than into endogenous acceptors. It is also 
interesting to note that increases in enzyme activities following injury 
and partial hepatectomy measured with exogenous acceptors are about one-
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TABLE 13
TRANSFER OF GALACTOSE-1'*C FROM UDP-GALACTOSE-TO 
N-ACETYLGLUCOSAMINE BY ENZYMES PRESENT 
IN WHOLE LIVER HOMOGENATES








Mean ± s.e.m. 3571 ± 1526 4638 ± 1787 4519 ± 1677
Difference (P) --- 0.025 <0.025
Assays were carried out as described in Methods. The values 
presented in this table represent only the amount of galactose-̂ **C 
present in N-acetyllactosamine-^C and has been corrected for the release 
of galactose-^**C resulting from nonspecific hydrolysis of UDP-galactose- 
l̂ C. Galactose-^**C transferred to the endogenous acceptors was excluded 
by passing the reaction mixture through Dowex columns.
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TABLE 14
TRANSFER OF GALACTOSE-^ **0 FROM UDP-GALACTOSE-^ "*0 TO EXOGENOUS 
ACCEPTORS BY ENZYMES PRESENT IN WHOLE LIVER HOMOGENATES
Acceptor Control Injury Partial Hepatectomy
dpm/mg acceptor/mg liver protein/hour
Endogenous Glycoproteins
Mean ± s.e.m. 6 8 8 ± 31 1075 ± 22 1346 ± 150
No. of Observations 5 5 5
Difference (P) <0 . 0 0 1 <0 . 0 0 1
Fetuin
Mean ± s.e.m. 4348 ± 148 5424 ± 217 6019 ± 642
No. of Observations 5 5 5
Difference (P) — —— <0.005 <0.025
Orosomucoid
Mean ± s.e.m. 4060 ± 185 4941 ± 110 6036 ±572
No. of Observations 5 5 5
Difference (P) --- <0 . 0 0 1 <0.025
Liver homogenates were diluted with 9 volumes of 1% Triton X- 
1 0 0 to solubilize enzymes and acceptors; 0 . 0 1  ml was used in the assay. 
Values for radioactivity incorporated into exogenous acceptors were 
obtained by subtracting the radioactivity incorporated into endogenous 
acceptors from the total radioactivity incorporated into exogenous and 
endogenous acceptors. Assays were carried out essentially as described 
in Methods for the "lactosamine synthetase assay," except that 3 mg of 
exogenous acceptors were used in each assay tube instead of N-acetyl­
glucosamine and the reaction was stopped with 5 % phosphotungstlc acid 
solution in 2 N HCl one hour after incubation.
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half of those measured with endogenous glycoprotein acceptors. The in­
creases in endogenous acceptors could be responsible for about one-half 
the total increases observed in monosaccharide transfer; the other half 
may be taken as representative of increases in actual enzyme activities or 
levels.
Time of Maximum Response Following Surgery 
The stimulation of plasma glycoprotein synthesis following 
injury and partial hepatectomy shows a characteristic time-response 
pattern. If the transferase increases observed in these studies are 
closely linked to plasma glycoprotein biosynthesis then one might expect 
a similar or identical time-response pattern to be exhibited by these 
enzymes as well. A preliminary experiment was carried out using 
mannosyltransferase as a representative enzyme. The results are shown 
in Figure 5. The time of maximal mannosyltransferase activity was 
approximately 18 hours following surgery, and is in agreement with maxima 
reported previously for cell-free amino acid incorporation and polysoinal 
aggregation (160), seromucoid synthesis (156), and glucosamine synthetase 
activity (249). Although an 18 hour peak was also observed after partial 
hepatectomy, a large part of this could have been due to a general stress 
response. If injury is used as a control for partial hepatectomy, the 
incorporation of mannose into microsomes of regenerating rat livers 
appears to reach a maximum between 24 and 36 hours after surgery, which 




















Figuru 5. Mannosyltransferase activity as a function of time following 
B  "#  , and Partial Hepatectomy expressed as percent of
Values are presented as means ± s.e.m. of 4 separate observations.
CHAPTER IV 
DISCUSSION
Biosynthesis of Glycoproteins on Polyribosomes:
Effect of Injury and Partial Hepatectomy
Many reports have been published recently supporting the concept 
that some polyribosomes are bound to membranes of the endoplasmic reticu­
lum whereas others are found free In the cytoplasm of eukaryotic cells 
(271-275). The functional differences between the two kinds of poly­
ribosomes in synthesizing secretory and sedentary proteins seem to be 
well documented (143-149) . Membrane-bound ribosomes are not only found 
in fully differentiated tissues, such as liver or pancreas which synthe­
size and secrete large amounts of proteins, but also in cells like HeLa 
cells, which have no apparent secretory function (276). It has been 
suggested that bound polysomes also synthesize membrane proteins in 
addition to secretory proteins and this might explain their presence in 
cells that do not secrete macromolecules (277).
The stress-induced increase in the amount of membrane-bound 
polysomes in the rat liver is another demonstration of functional differ­
ences between free and bound polysomes. The present work supports previ­
ous findings (152-154, 174) that glycoproteins are primarily synthesized 
on membrane-bound polysomes. Since the ratio of membrane-bound polysomes 
to free polysomes doubles after injury, one might expect to see an
79
80
increase in the RER. In the regenerating liver, on the other hand, the 
amount of free polysomes is greatly increased and the bound to free 
polysome ratio actually decreases. One way of explaining this observa­
tion would be to assume that in a dividing cell mass there is a greater 
need for the synthesis of non-exportable, intracellular proteins than 
for secretory proteins. If membrane proteins are also synthesized on 
membrane-bound polysomes, one might also expect to see an increase in 
bound polysomes in the regenerating liver, since membrane synthesis is 
enhanced to meet the growing needs of the dividing cells. The present 
work does not seem to support this idea.
Recent reports (.271, 272) that steroid hormones may be involved 
in promoting the binding of ribosomes to the membranes are of particular 
interest in connection with the stress-induced increases in membrane- 
bound polysomes. Since stress is known to elicit a greater secretion of 
adrenocortical hormones (74), corticosteroids may play an important role 
in the increased binding of ribosomes to the membranes. A study devoted 
to the effects of adrenalectomy, castration and hypophysectomy on the 
stress-induced response of glycoprotein synthesis certainly deserves 
attention. Since corticosterone has been found to enhance binding and 
hydrocortisone to inhibit binding of ribosomes to rat liver membranes 
treated with EDIA (271), the ratio of these two hormones might be impor­
tant for ribosome-membrane interactions and could explain some of the 
controversies regarding the action of corticosteroids on glycoprotein 
synthesis.
Since most of the monosomes and disomes were supposedly 
eliminated during the isolation of polyribosomes by the method of Blobel
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and Potter (141), it is not surprising that the polysomal preparations 
from control and experimental animals were found to be equally active in 
amino acid incorporating systems and had the same ENA/protein ratios. 
Although the amount of polysomes is increased after stress, their spe­
cific activities do not seem to be changed significantly. Thus it is the 
quantity and not the quality of polysomes that is changed by stress.
Effect of Injury and Partial Hepatectomy on Monosaccharide 
Incorporation into Subcellular Fractions
Injury and partial hepatectomy were generally followed by an 
increase in monosaccharide incorporation into the various subcellular 
fractions examined in these experiments. Since measured, uniform amounts 
of sugar nucleotides were used in the in vitro systems, any Increases in 
monosaccharide transfer have to be ascribed to increases in either the 
concentration of endogenous glycoprotein acceptors, or in the activities 
of the transferases, or possibly both. Since the microsomal incorpora­
tion of all three sugars increased to the same extent (40%) after injury, 
it may be assumed that all three sugars were added to the same acceptors. 
Microsomes from the regenerating livers, however, did not show any sig­
nificant increases in N-acetylglucosamine or galactose incorporation, 
although mannose incorporation was higher than that seen after injury. 
There could be two reasons why microsomes from the regenerating liver did 
not show a higher activity in N-acetylglucosamine and galactose incorpo­
ration: (i) The concentration of endogenous acceptors was not increased
after partial hepatectomy, or (ii) a part of these endogenous acceptors 
was unable to accept N-acetylglucosamine or galactose residues. The 
first possibility can be ruled out on the basis of the following
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arguments: (a) An increase in the rate of plasma glycoprotein biosyn­
thesis normally seen after partial hepatectomy, could not occur without 
an increase in acceptor molecules; (b) Since all three sugars are pre­
sumably added to the same endogenous acceptors, it seems improbable that 
the concentration of the mannose acceptors was increased after partial 
hepatectomy without changing the concentrations of N-acetylglucosamine 
and galactose acceptors. Therefore, the second possibility that a part 
of the acceptors was not yet ready to accept the latter two sugars seems 
to be more reasonable.
When one carefully examines the sugar sequences of the "inner 
core" of glycoproteins one finds that the innermost N-acetylglucosamine 
residue is usually followed by mannose and then by N-acetylglucosamine 
and galactose:
-Asn- (GlcNAc) - (jNan) - (GlcNAc) - (Gal) - (NANA)
If it is assumed that the innermost N-acetylglucosamlne residues are 
largely attached to the nascent polypeptide chains in vivo, the results 
obtained above can be explained as follows : whereas the incorporation of
all three sugars (mannose, N-acetylglucosamine, and galactose) into micro­
somes is increased following injury, the in vivo incorporation of mannose 
cannot keep pace with the increased synthesis of endogenous acceptors 
after partial hepatectomy. Consequently, some of these acceptor molecules 
lack mannose and, therefore, cannot act as acceptors for subsequent N- 
acetylglucosamine and galactose residues. In other words, these acceptors 
are "mannose-deficient."
The above explanation is further supported by results obtained 
in the experiments with sugar nucleotide supplementation. When unlabeled
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6 DF-mannose was Included In the reaction mixture, the Incorporation of 
N-acetylglucosamine and galactose was stimulated to a greater extent 
into microsomes from the regenerating liver than into equivalent prepara­
tions from normal controls or injured animals. It is, therefore, clear 
that the endogenous acceptors as well as the transferase(s) for mannose 
are present in higher concentrations in microsomes from the regenerating 
liver than in microsomes from control livers. This leaves GDP-mannose, 
or another early mannose intermediate, as a limiting substrate in the 
regenerating liver, which, when added from outside, causes marked stimu­
lation of mannose incorporation into microsomes. The results presented 
in Figure 4 are also consistent with the idea that the regenerating liver 
exhibits a mannose transfer deficiency. Thus the supply of mannose could 
be a natural method of regulation of glycoprotein biosynthesis under 
certain conditions.
If the mannose deficiency concept proves to be true, it could 
also provide a reasonable explanation for a relatively poor incorporation 
of N-acetylglucosamine into postmicrosomal particles isolated from the 
regenerating liver.
The study of glycoprotein side-chain microheterogeneity has not 
yet been extended to glycoproteins synthesized by stressed or by partially 
hepatectomized animals, but it would be interesting to see if there is an 
, increase in heterogeneity under these conditions, expecially if there is 
a deficiency of mannose in the regenerating liver. Experiments by Ali 
and Chandler (278) using concanavalin A as an investigative tool to 
observe changes in glycoprotein oligosaccharides (microheterogeneities) 
gave some support to the idea that plasma proteins synthesized by
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regenerating livers have altered side-chains.
The extension of the sugar incorporation studies to microsomal 
subfractions showed that the mannosyltransferase activities were local­
ized primarily in the rough microsomal fraction, while the galactosyl­
transferase activities were found mainly in the smooth membrane fractions. 
This is in good agreement with results reported by others (209-212). 
Glucosaminyltransferase activities, however, were foupd to be higher in 
smooth microsomes than rough microsomes. These results agree with those 
reported by several investigators (209, 212) but contradict those re­
ported by Molnar and coworkers (216). Our results are compatible with 
the idea that the innermost N-acetylglucosamine residues are largely 
attached to the nascent polypeptides in vivo and that the incorporation 
observed in vitro represents primarily the addition of those N-acetyl­
glucosamine residues which are peripheral to mannose. This is also 
supported by studies on the in vivo incorporation of glucosamine into 
smooth microsomes, which were twice as active in glucosamine uptake as 
were rough microsomes. The discrepancies in results obtained by various 
investigators may be due to differences in the preparation of rough and 
smooth microsomes. Since Molnar and coworkers (216) have not reported 
on the RNA or phospholipid content of their preparations, it is not 
possible to compare our preparations with theirs. A comparison of the 
rough versus the smooth microsomal fractions on the basis of the specific 
activities of monosaccharide incorporation alone may, however, be decep­
tive since the rough microsomes contain large amounts of ribosomal pro­
teins which will tend to lower their specific activities.
The increases observed in mannose incorporation into the total
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microsomes after partial hepatectomy can be traced to the rough micro­
somal fraction and those in N-acetylglucosamine and galactose incorpora­
tion following injury can be traced to the smooth microsomes. Since 
stimulation' of N-acetylglucosamine and galactose incorporation by GDP- 
mannose was much greater in smooth microsomes than in rough microsomes, 
one might suppose that glycopeptides were being passed on from the rough 
to the smooth microsomes prematurely, lacking an adequate number of 
mannose residues.
The Golgi-rich fractions isolated from control and experimental 
animals did not differ in in vitro monosaccharide incorporating abilities 
(Table 11); i.e., they were equally active on a mg protein basis. Thus, 
in order to achieve an overall increase in glycoprotein synthesis, the 
transport of these macromolecules through the Golgi membranes must be 
enhanced, provided all glycoproteins are processed and secreted via this 
organelle. This can be accomplished by (a) increasing the amount of 
Golgi membranes and, therefore, the number of multiglycosyltransferase 
units per cell, (b) increasing the rate Of flow of glycoproteins through 
these membranes, or (c) both.
If one accepts the conclusions of Roseman and coworkers (168) 
and Schachter and colleagues (279) that galactosyl- and s ialy trans feras es 
are specifically confined to the Golgi membranes, then the above results 
can be explained on.the basis of an increase in these membranes following 
injury and partial hepatectomy, since the total galactosyltransferase 
activity in whole liver homogenates was increased 25-35% under these 
conditions (Table 14). The phospholipid to DNÂ ratios (Table 10), which 
were supposed to represent the amount of membranes per cell, did not.
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however, provide any evidence for such an Increase.
It is possible that the amount of Golgi membranes remained 
constant but injury and partial hepatectomy stimulated the rates of trans­
port of glycoproteins through these membrapes. If the membranes have a 
limited capacity to bind acceptors, then it is possible that the in vitro 
assays would fail to detect these rate increases. Our results showed 
that endogenous acceptors "piled up" in the RER and SER after injury and 
partial hepatectomy, indicating that the Golgi processing might be rate- 
limiting. Thus, if the activity of the Golgi membranes to process 
glycoproteins was increased, this increase was.not enough to prevent 
the "piling-up" and was not detectable on the specific activity basis in 
the in vitro assays.
Glycolipids as Intermediates in the Biosynthesis of Glycoproteins
The linear correlations observed between N-acetylglucosamine,
galactose, and mannose incorporation into glycoproteins and glycolipids
strongly suggests that the biosyntheses of these two classes of macro- 
*
molecules are closely related. Since the linear correlations between the 
two were not affected by injury or partial hepatectomy, it may be.con­
cluded that glycolipid synthesis increased concomitantly with an increase 
in glycoprotein synthesis. The incorporation of mannose, in particular, 
into glycolipids and glycoproteins (Figure 4) certainly supports this 
view. These results are consistent with and support the earlier sugges­
tions (241-245) that glycolipids* may serve as intermediates in the bio­
synthesis of glycoproteins. Although glucosamine and galactose are 
constituents of many other glycolipids, such as ceramides and cerebre­
sides, mannose is not found as a component of these glycolipids (280).
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It seems probable, therefore, that these glycollplds represent llpld 
Intermediates In the biosynthesis of glycoproteins and are not glyco­
llplds of the kind of ceramides and cerebrosldes. Although the results 
presented In this dissertation seem to fit nicely Into the "llpld Inter­
mediate hypothesis," other possible explanations should not be Ignored. 
The linear relationships observed between glycollplds and glycoproteins 
suggest only that their syntheses may be regulated together. It Is quite 
possible, however, that the syntheses of the two are Increased Independ­
ently and that one may not necessarily be a precursor to the other. The 
"llpld Intermediate hypothesis" Is still at an early stage of development 
and open to many questions. For Instance, It Is not clear whether the 
synthesis of glycollplds Involves the same transferases used for glycor 
protein synthesis or different enzymes. What Is the precise nature of 
these Intermediates and how are they synthesized? Since purified 
glycosyltransferases are capable of transferring monosaccharides directly 
from sugar nucleotides to purified glycoprotein acceptors In vitro (231), 
one wonders If'the synthesis of glycollplds Indeed precedes glycoprotein 
synthesis In vivo. A definite proof that glycollplds serve as Inter­
mediates In the biosynthesis of, glycoproteins certainly requires Identi­
fication of these Intermediates, their chemical synthesis, and demonstra­
tion In vivo and In vitro that they Indeed are Intermediates In the 
biosynthesis of glycoproteins.
Effect of Injury and Partial Hepatectomy on' 
the Activities of Glycosyltransferases
The Initial rate studies were the first In this series to In­
dicate that the activities of glycosyltransferases were Increased
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following injury and partial hepatectomy. Since the initial rates of 
transfer of all three sugars studied were found to be consistently higher 
in microsomes isolated from injured animals when compared to those from 
normal controls, it was tentatively concluded that the activities of all 
three microsomal transferases were increased after stress. In the case 
of partial hepatectomy, the rate of mannose transfer was found to be even 
higher than in the case of injury.
The rates of N-acetylglucosamine and galactose transfer-, how­
ever, were higher than the control values only up to 2 minutes incubation 
time, after which time they leveled off. This could either mean that the 
enzymes were inactivated or that the acceptor sites were fully saturated 
at this point. The inactivation of enzymes seems unlikely since supple­
mentation with GDP-mannose was effective in stimulating N-acetylglucosa­
mine and galactose transfer to endogenous proteins. Moreover, galactose 
transfer was greater after partial hepatectomy than in controls when 
measured with exogenous acceptors. Therefore, these results can be ex­
plained by assuming that the supply of endogenous acceptor sites for 
N-acetylglucosamine and galactose were exhausted after a 2-minute incuba­
tion of microsomes isolated from the regenerating liver. The initial 
rate experiments performed with endogenous acceptors were not definitive, 
however, but only suggestive of increases in enzyme activities and should 
be repeated using exogenous acceptors.
The use of exogenous glycoprotein acceptors in the transferase 
assay mixtures clearly demonstrated that there was a significant increase 
in the activities of galactosyltransferases following injury and partial 
hepatectomy. The increases in galactosyltransferase activities measured
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by three different exogenous acceptors (N-acetylglucosamine, and the 
fetuin and orosomucoid derivatives) were remarkably similar (about 30%). 
This is in good agreement with the previous reports (168, 232) that 
galactose is transferred to N-acetylglucosamine by the same enzyme that 
transfers this sugar to the glycoprotein acceptors.
The activities of N-acetylglucosaminyl- and mannosyltransferases 
could not be assayed with exogenous acceptors because of the non­
availability of sufficiently pure N-acetylglucosaminidase and mannosIdase 
to prepare them, but it appears from the initial rate studies that their 
activities were also increased following stress. In fact, if the incor­
poration of galactose and that of N-acetylglucosamine into the same 
samples of liver microsomes isolated from control, injured and partially 
hepatectomized animals are plotted against each other on a scattergram, 
a good linear correlation is observed between the two (Figure 6 ). Since 
the linear relationship between N-acetylglucosaminyl- and galactosyl­
transferase activities was not disturbed after injury or partial hepa­
tectomy, there is a good possibility that the activities of both these 
enzymes were increased in parallel under these conditions. Similarly, 
mannosyltransferase activities were probably also increased following 
injury and partial hepatectomy, but confirmation of this requires the 
use of exogenous substrates.
Hudgin et al. (279) recently reported increases in sialyl- 
transferase activities in the livers of rats bearing Morris hepatomas 
7777, 7800, and 5123D. They were also able to see a significant increase 
in N-acetylglucosaminyltransferase activity in the livers of animals 
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5123D. Results obtained In the present study are in good accord with the 
above reports and together suggest that the activities of most, if not 
all, transferases are increased after stress. These findings also sup­
port the thesis that the mechanisms responsible for producing the stress- 
specific response are remarkably similar no matter whether the stress 
stimulus is applied by physical or pathological means.
In the light of the present and. previously reported work, it 
seems logical to propose that stress stimulates the .synthesis of both the 
protein as well as the carbohydrate moieties of glycoproteins simulta­
neously. Since the regulatory control is quite specific in that the 
concentrations of only a selected number of glycoproteins increase after 
stress, one will have to assume that this specificity is conferred prima­
rily by a control on the synthesis of the protein moiety. An increase in 
the activities of glycosyltransferases may be considered obligative to 
increases in the concentrations of apoprotein acceptors and some carbo­
hydrate precursors. There is, however, one way that these transferases 
can also exert a specific effect on glycoprotein synthesis. If it is 
assumed that the carbohydrate moiety of each glycoprotein is synthesized 
by a separate set of transferases, then the activities of only a few 
specific "sets of glycosyltransferases" might be increased after stress. 
There is no clear-cut evidence as yet that the synthesis of the carbo­
hydrate moiety of each glycoprotein requires separate and specific trans­
ferases. Bosmann's findings that the activity of N-acetylglucosaminyl- 
transferase purified from guinea-pig liver was much higher when measured 
with fetuin acceptors than that measured with orosomucoid acceptors (231) 
raises the possibility that the transferases might be protein-specific.
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The results of the present study do not seem to support this idea. The 
fact that rat liver enzyme can use glycoprotein acceptors prepared from 
human or calf serum proteins as substrates quite efficiently, negates the 
idea of such a high specificity. In fact, glycoprotein acceptors and 
N-acetylglucosamine compete for the same sites on galactosyltransferase 
(232).
It is interesting to note that the time of maximal activity of 
glycosyltransferases following stress coincides with the time when the 
synthesis of the apoprotein part,of glycoproteins is maximal. This 
further supports the view that the syntheses of the carbohydrate and 
protein moieties of glycoproteins are regulated simultaneously. In view 
of the complexity of extending regulatory control over a number of 
synthetic processes in response to stress, it appears unlikely, although 
not impossible, that only one hormone or factor is responsible for bring­
ing about all these changes. It may be more reasonable to think that 
these changes are a result of a collective effort of several factors or 
hormones released after stress. What these hormones are remains to be 
clarified. The area of hormonal regulation of glycoprotein synthesis 




Regulation of glycoprotein biosynthesis in the rat liver was 
studied using injury and partial hepatectomy as experimental models.
This work included studies on the functional differentiation between free 
and membrane-bound polysomes, and the in vitro transfer of monosaccharides 
to endogenous and exogenous glycoprotein acceptors by enzymes present in 
the microsomal and Golgi-rich fractions.
Marked alterations in the relative distribution of membrane- 
free and membrane-bound polysomes were detected following injury and 
partial hepatectomy. Injury caused a two-fold increase in the membrane- 
bound to free polysome ratio, primarily due to an increase in membrane- 
bound polysomes. Partial hepatectomy, on the other hand, resulted in a 
decrease in membrane-bound to free polysome ratio, mainly because of an 
increase in free polysomes. These observations were consistent with the 
suggested functional segregation of the two polysomal populations, that 
is, the exportable secretory porteins are synthesized on membrane-bound 
polysomes, while the non-exportable intracellular proteins are synthesized 
on free polysomes.
Purified, detergent-treated, polysomes from control and experi­
mental animals showed comparable activities in cell-free amino acid
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Incorporation systems and injury or partial hepatectomy caused no signif­
icant changes In the RNA to protein ratios of these preparations.
The In vitro Incorporation of N-acetyIglucosamlne, galactose 
and mannose Into glycoproteins and glycollplds of microsomal fractions 
was significantly higher after Injury or partial hepatectomy than In 
normal controls. The endogenous acceptors present In mlcrosomes Isolated 
from regenerating livers appeared to be deficient In mannose, suggesting 
a limitation In the supply of some mannose Intermediate(s) after partial 
hepatectomy. The regulation of the mannose supply may be a natural means 
of regulation of glycoprotein biosynthesis.
Golgl-rlch fractions Isolated from control. Injured and par­
tially hepatectomlzed animals showed no significant differences In the 
rate of N-acetyIglucosamlne or galactose Incorporation In vitro. 
Similarly, no significant differences could be detected In the morphology 
of the three preparations by electron microscopic examination.
A linear correlation between the Incorporation of monosaccha­
rides Into glycoproteins and glycollplds was established for all three 
sugars studied, which Is consistent with the possibility that glyco­
llplds may be Intermediates In the biosynthesis of glycoproteins.
Initial rate studies Indicated that the Increases In the rates 
of monosaccharide transfer to endogenous glycoprotein acceptors following 
Injury and partial hepatectomy were, In part, due to Increases In the 
activities of the glycosyltransferases. Galactosyltransferase activities 
assayed using fetuin and orosomucoid derivatives as exogenous acceptors 
showed a 30-40% Increase In the enzyme activity In whole liver homoge- 
nates, following Injury and partial hepatectomy. The same results were
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obtained when N-acetylglucosamine was used as an exogenous acceptor. The 
activities of N-acetylglucosaminyl- and mannosyltransferases were not 
measured by using exogenous acceptors, but a linear correlation was ob­
served between galactose and N-acetylglucosamine transfer to endogenous 
acceptors of liver mlcrosomes isolated from control, injured and par­
tially hepatectomlzed animals. It is suggested that the activities of 
all three transferases, are Increased under these conditions.
The in vitro transfer of mannose measured as a function of time 
after stress reached a peak at 18 hours, a value in excellent agreement 
with that reported for maximal incorporation of amino acids into micro- 
somes, maximal polysomal aggregation, maximal glucosamine synthesis and 
overall increase in plasma glycoprotein biosynthesis.
These results are discussed in relation to the overall coordi­
nated synthesis of the carbohydrate and apoprotein moieties of glyco­
proteins .
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APPENDIX
Isolation of Fetuin
Fetuin was isolated by the method of Spiro (281). Two volumes 
of 0.03 M zinc acetate solution in 28.5% ethanol were added dropwise to 
300 ml of fetal calf serum at -5® with constant stirring. The mixture 
was adjusted to pH 6.4 with 1 M NH^OH-NH^Cl buffer, pH 10.4, in 19% 
ethanol and was allowed to stand for 15 hours at -5°. This step precipi­
tated hemoglobin and most of the plasma proteins other than fetuin. The 
precipitate was removed by centrifugation and discarded. Enough 1 M 
barium acetate at -5® was added to the supernatant to give a final con­
centration of 0.02 M with respect to barium. Ethanol was prechilled to 
-70° and was added dropwise to the mixture to obtain a final concentra­
tion of 25%. The mixture was adjusted to pH 6.7 and allowed to stand for 
2 hours. A slight precipitate appeared which was removed by centrifuga­
tion and discarded. Fetuin was precipitated from this supernatant by the 
dropwise addition of 95% ethanol (-70°) at -10° to give a final ethanol 
concentration of 40%. After standing for 12 hours, the fetuin precipi­
tate was recovered by centrifugation, dissolved in 50 ml of 0.1 M tri­
sodium citrate, and dialyzed for 3 days against 4 changes of 4 liters of 
distilled water. The dialyzed solution was passed through a mixed-bed 
ion-exchange resin to remove traces of heavy metals and was lyophilized 
and stored at -2 0 ®.
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Isolation of Orosomucoid 
Orosomucoid was Isolated from human plasma as described by 
Ulchon et al. (282). To a measured volume of plasma, enough ammonium 
sulfate was added dropwise from a 4 M solution, pH 7.0, at 0°, to obtain 
a final ammonium sulfate concentration of 2.4 M. After standing for 12-16 
hours at 0-4°, the precipitate was removed by centrifugation, washed with 
2.4 M ammonium sulfate solution, pH 7.0, and the washings were added to 
the previous supernatant. The combined supernatant was adjusted to pH
5.0 with 1 N H2 SO4  and allowed to stand for 2 hours. The precipitate was 
removed by centrifugation and washed with 2.4 M ammonium sulfate, pH 5.0. 
The precipitate was discarded and the washings were added to the super­
natant obtained above. Solid ammonium sulfate was added to the combined
supernatants to bring the solution to saturation, after which the pH 
dropped to 4.0. The mixture was allowed to stand for 24 hours at 0-4°.
The precipitate formed was collected, dissolved In water and dialyzed
against running tap water and then distilled water until all ammonium
sulfate was removed. The dialyzed solution was adjusted to a pH of 4.65, 
and a total molarity of 0.06 by adding sodium acetate (0.02M)-sodium 
chloride (0.08M) buffer. Cold 95% ethanol was then slowly added to this 
solution at 0 °, with constant stirring, to obtain a final ethanol con­
centration of 50%. After standing for several hours In the cold, the 
precipitate was removed and discarded. Orosomucoid was precipitated 
from the supernatant by raising the concentration of ethanol In the solu­
tion to 80%. The final precipitate of orosomucoid was collected by 
centrifugation, dissolved In water and dialyzed against distilled water. 
The orosomucoid was lyophilized and stored at -20°.
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Preparation of Exogenous Glycoprotein Acceptors 
The acceptors for galactose were prepared both from fetuin and 
orosomucoid by removing terminal slallc acid and galactose residues. 
Slallc acid was removed from the glycoproteins by acid hydrolysis at pH
1.0 (10 mg protein/ ml of 0.1 N H2 SO4 solution) for 1 hour at 80°. The 
release of free slallc acid was monitored by the method of Warren (283), 
and total slallc acid was measured by the method of Svennerholm (284). 
Acid hydrolysis removed about 98% of the slallc acid residues present In 
the glycoproteins. After hydrolysis, the solutions were neutralized with 
0.1 N NaOH, dialyzed exhaustively against distilled water at 4°, and 
lyophilized.
The dialyzed glycoproteins were dissolved In 0.01 M potassium 
phosphate, pH 7.0, (2 mg proteln/ml buffer) and were Incubated with 8 - 
galactosldase (50 units/mg glycoprotein) at 37° under toluene for 200 
hours. The release of free galactose was measured by the galactose 
oxidase method (Galactostat: Worthington). The procedure removed approx­
imately 70% of the theoretical amount of galactose In fetuin or oroso­
mucoid. After Incubation, 8-galactosldase was precipitated from the 
reaction mixture by the addition of perchloric acid to a final concentra­
tion of 0.34 N. The precipitate containing 3-galactosldase was discarded 
and the supernatant was neutralized with 0.5 N KOH. The potassium 
perchlorate precipitate was removed and the solution was dialyzed against 
distilled water and lyophilized.
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